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CHAPTER I

INTRODUCTION

In vertebrates four major systems of intercellular
communication exist: the neural, the endocrine, the
neuroendocrine, and the immune systems.

For many years,

evidence has accumulated linking the neural, the endocrine,
and the neuroendocrine systems, but the immune system was
often viewed as essentially autonomous (Bateman et al.,
1989). Current investigations, however, reveal information
as to how the immune system is able to communicate with
other systems.

Evidence delineating the structural and

functional connections between the central nervous system
and the immune system has propelled research in this area to
unprecedented expansion (Arnason, 1991; Harbour-McMenamin et
al., 1986; Hiestand et al., 1986; Smith et al., 1982; Smith

and Blalock, 1981) .

Identification of shared informational

molecules such as cytokines, hormones, and neuropeptides
provides molecular evidence for bidirectional communication
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between these systems (Arnason, 1991; Carr and Blalock,
1991) .

One limb of this bidirectional communication may

occur through the cytokines tumor necrosis factor-a,
interleukin-1, and interleukin-6, which have all been shown
to be potent modulators of the hypothalamic-pituitaryadrenal axis.

More specifically, interleukin-1 has been

shown to enhance sympathetic nerve activity (Haefli et al,
1993; Ichijo et al., 1994), modify the neuronal gene
expression of molecules such as substance P (Jonakait,
1993), and is synthesized and released by cultured
sympathetic neurons (Frieden et al, 1992).

Studies indicate

that immune-derived peptides may also play a role in
modulating neural/endocrine function.

In 1981, Blalock and

Smith reported that human peripheral blood lymphocytes (PBL)
infected with Newcastle disease virus (NDV) produced the
proopiomelanocortin (POMC)-derived peptides,
adrenocorticotropin (ACTH) and Beta-endorphin (Smith and
Blalock, 1981) .

Interestingly, in studies with mice

previously hypophysectomized to eliminate the pituitary as
asource of ACTH, challenge with NDV significantly elevated
plasma corticosterone levels (Smith et al., 1982).
Furthermore, glucocorticoids released in response to
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immunoreactive-ACTH were shown to negatively feedback on the
immune cells to prevent further release of ACTH or
endorphin. Thus, products of the immune system were found to
affect output from the adrenal cortex.
More recent investigations have vastly expanded the
list of peptide signalling molecules found to be synthesized
and released by activated immune cells.

These peptides

include but are not limited to thyrotropin (TSH)
al., 1983), chorionic gonadotropin (CG)

(Smith et

(Harbour-McMenamin

et al., 1986), growth hormone (GH) and prolactin-related
peptides (Hiestand et al., 1986).

Evidence suggests that

these peptides may serve an autocrine/paracrine function
with cells of the immune system in addition to the
traditional axes

(Plaut, 1987).

Preliminary studies

suggest that there is yet another peptide of immune origin
which, in contrast to those mentioned above, is able to
stimulate catecholamine release from the adrenal medulla
(Jones et al., 1993; Wang, 1993).

Furthermore, preliminary

experimental evidence in preparation for this dissertation
work indicated that known peptide chromaff in cell
secretagogues are not responsible for the observed
phenomena.

Such peptides include vasoactive intestinal
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peptide (VIP), bradykinin, angiotensin II, and pituitary
adenylyl cyclase activating polypeptide (PACAP)

(Isobe,

1993; Livett and Marley, 1993; Marley, 1987),

This

previously uncharacterized peptide has also been shown to
cause epinephrine secretion comparable to maximal neural
stimulation but at an attenuated rate.

Based on preliminary

studies from this (Jones et al., 1993; Wang, 1993; Zhou and
Jones, 1993) and other laboratories (Seidler and Mills,
1989) and the lymphoid-adrenal cortical interaction
demonstrated by Smith and Blalock, a lymphoid-medullary
interaction through a yet undescribed lymphocyte product is
not surprising.
A variety of stressors, both physiologic and
psychologic, activate a cascade of events which leads to the
release of glucocorticoids and catecholamines from the
adrenal gland by both neural and hormonal stimulations.

The

catecholamines, epinephrine and norepinephrine, are pivotal
regulators of many physiologic events in man and have been
shown to be potent modulators of the immune response.
Immune cells have been shown to express both functional
beta-2 (Krieger, 1983; Plaut, 1987) as well as alpha-1

adrenoreceptors (Sanders and Munson, 1985) which account for
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the well-documented direct action of catecholamine on immune
function (Malec et al., 1985; Mihran-Davis et al, 1991;
Murray et al., 1993; Rinner et al., 1992).

Catecholamine

action on immune cells has long been viewed as being
suppressive.

This suppressive action ranges from decreases

in T helper/T suppressor cell number ratio (Malec et al.,
1989) to an inhibition of natural killer cell cytotoxicity
(Whalen and Bankhurst, 1990).

Interestingly, current

literature indicates that catecholamine action may also act
to enhance the immune response (Arnason, 1991) .

Data

indicate that not only stress itself, but characteristics of
the stressor such as duration (acute/chronic) and
intensity/severity are also important variables modulating
stress-induced immunologic alterations.

For example, the

same stressor can have a positive or negative relationship
with immune responses depending on the intensity, such that
less severe or acute stressors correlate with enhanced
immune response, while potent/chronic stressors seem to
correlate with depressed immunologic response (Rinner et
al.

I

1992) •

Such immunoenhancement may serve to protect

individuals for short periods of stress.

Ultimately,

chronic stress, such as that associated with long term
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illness, and subsequent maintained elevations in plasma
catecholamine appears to result in the well documented
immunocompromising aspects of the stress response (Sanders
and Munson, 1985) .

To date there have been no successful

therapeutic approaches to control stress-induced
immunosuppression.

Identifying immune-derived signal

molecule(s) that modulate stress hormone release may lead to
therapeutic manipulation by suppressing or enhancing
bioactive peptide release and/or activity.
This dissertation research has built upon previous
studies which presented evidence for the non-neurogenic
stimulation of adrenal medullary catecholamine release.
Zhou and Jones (1993) demonstrated in conscious adrenal
denervated rats that plasma epinephrine levels were
significantly elevated 90 minutes after bacterial endotoxin
challenge.

This epinephrine elevation was approximately

one-third that observed in non-denervated endotoxin
challenged rats suggesting that a non-neural mechanism may
comprise part of medullary epinephrine release.
findings have been reported in newborn rats.

Related

Ganglionic

blockade in endotoxin-challenged newborn animals was unable
to prevent a rise in plasma catecholamine also suggesting a
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non-neurogenic stimulation of adrenal medullary
catecholamine release (Seidler and Mills, 1989).
experiments have demonstrated that factor(s)

In vitro

released by

immune cells may potentially act in vivo to modulate
medullary catecholamine release (Jones et al, 1993; Wang,
1993) .

Experimental evidence indicates that these factor(s)

are small molecular weight peptide(s)

(<3,000) and are

present and active in a variety of species (bovine, porcine,
human) .
Considering the clinical importance of stress-induced
immunosuppression and the potential ramifications of
immunomodulation of the stress response, understanding the
role of various immune-derived signalling molecules in this
process may provide pivotal information and a basis for
future therapeutic intervention.

This dissertation project

was designed to begin to elucidate the components of the
immune system which may play an role in communication
between the immune system and the neuroendocrine system via
the adrenal medulla.

The hypothesis is that mononuclear

cells release a novel bioactive peptide which stimulates
adrenal medullary secretion in a calcium-dependent manner.
The specific aims of the following studies include: 1) the
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characterization of peptide-mediated secretion with an
emphasis on the role of calcium in peptide-induced
exocytosis, 2) the identification of the specific
mononuclear cell subset(s) involved in release of the
bioactive peptide and assessment of feedback inhibition by
epinephrine on further peptide release, 3) the further
isolation and characterization of this bioactive peptide
using molecular biological and immunological techniques, and
4) the examination of the potential significance of this
peptide in endotoxicosis and related shock states.

CHAPTER I I

REVIEW OF RELATED LITERATURE

A. The Catecholamines

I. Physiologic Role in the Stress Response

The catecholamines, epinephrine and norepinephrine, are
pivotal regulators of many physiological events in man.
Increased circulating levels of catecholamine are known to
mediate arteriolar constriction, elevation of blood glucose
and free fatty acids, as well as positive chronotropic and
inotropic effects.

In 1929, Walter Cannon first associated

these and other physiologic changes with increased
circulating catecholamine in his discussion of a
phenomenology referred to as the "fight or flight" response.
This reaction occurs when animals, including man, perceive
danger (cognitive stimuli) and prepares the animal to
respond to the threat through either direct conflict
("fight") or escape ("flight") .
9

An increased level of
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circulating catecholamine, however, is also mediated by
stimuli not recognized by the cerebral cortex (non-cognitive
stimuli) .

Examples of non-cognitive stimuli include

bacteria, tumors, and viruses.

Thus, both psychological and

physiological stimuli can evoke a classic stress response.
Documented actions of the catecholamines have been
classified into four broad categories which include: 1)

a

peripheral excitatory action on certain smooth muscle types
(i.e. blood vessels of the skin, mucous membranes) and on
some sweat and salivary glands; 2) a peripheral inhibitory
action on other types of smooth muscle (i.e. gut wall,
bronchial tree); 3) a cardiac excitatory action responsible
for positive chronotropic and inotropic effects; and 4)
metabolic actions such as glycogenolysis and lipolysis.
More recent investigations, however,

have expanded this

list of adrenergic actions to include modulation of immune
function.

The mechanisms and potential implications of this

neuroendocrine-immune interaction are just beginning to be
understood.

II. Sources and Secretion of the Catecholamines
The major sites of release of the catecholamines are
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the postganglionic efferent sympathetic terminals and the
adrenal gland.

The adrenal gland, located in the abdominal

cavity rostral to the kidneys, consists of two anatomically
and embryologically distinct structures - the outer cortex
and the inner medulla.

While the glucocorticoid-secreting

cortex is of mesodermal origin, the inner medulla, source of
the catecholamines, is of neuroectodermal origin.

During

embryonic development, under influence of the
corticosteroids, the sympathoadrenal progenitor cells of the
neural crest migrate to the adrenal medullary cavity and
differentiate into chromaffin cells (Anderson and Axel,
1986) .

Upon settling in the adrenal gland, the chromaffin

cells are innervated by preganglionic sympathetic neurons of
the splanchnic nerves and become part of the sympathetic
nervous system.
These adrenal medullary chromaffin cells synthesize,
store and secrete catecholamines in response to a variety of
stimuli.

While the list of chromaffin cell secretagogues

has expanded, Feldberg et al.

(1934) were the first to

document that the release of acetylcholine from the
splanchnic nerve was the immediate neurologic stimulus that
induced adrenal medullary catecholamine secretion.

This
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group observed that stimulation of the splanchnic nerve led
to the appearance of acetylcholine (ACh) in the blood of the
feline adrenal vein and, ultimately, catecholamine
(adrenaline/epinephrine) secretion from the adrenal gland.
Furthermore, Feldberg and colleagues demonstrated both
muscarinic and nicotinic agonists could stimulate
catecholamine secretion indicating the presence of both
cholinergic receptor types on chromaffin cells.
Depending on the animal model, activation of either the
nicotinic or the muscarinic receptor can lead to chromaff in
cell catecholamine secretion (Wakade and Wakade, 1983).
Although knowledge of the exact mechanism of chromaffin cell
exocytosis is poorly understood, one common feature of all
models is that catecholamine secretion is dependent on an
increase in intracellular calcium.

The source of this

calcium may be from internal stores, as is the case with
muscarinic receptor stimulation, or from the influx of
extracellular calcium, as with nicotinic receptor
activation.

Muscarinic receptor activation, the sole

stimulus for chick adrenal medullary catecholamine secretion
(Douglas, 1975) and non-functional in bovine chromaffin
cells (Cheek and Thastrup, 1989), leads to the liberation of
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diacylglycerol (DAG) and inositol trisphosphate (IP 3 ) from
membrane phosphatidylinositols (phosphatidylinositol
bisphosphate, PIP 2 ) .

The liberated IP 3 then binds to its

intracellular receptor and, ultimately, stimulates calcium
release from internal stores.

Interestingly, chromaffin

cells appear to possess two different, spatially distinct
intracellular calcium stores - an IP 3 sensitive store and a
caffeine sensitive store (Burgoyne et al., 1989).

In bovine

chromaffin cells, evidence indicates that the caffeine
sensitive store is involved in calcium homeostasis rather
than exocytosis (Cheek et al., 1990).
Unlike muscarinic receptor activation, the
catecholamine secretion in response to nicotinic receptor
stimulation requires the availability of extracellular
calcium.

Activation of nicotinic receptors is functionally

important in cat (Douglas, 1975), dog (Tsujimoto and
Ashidawa, 1975), and rat (Yoshizaki, 1973) and is the sole
cholinergic stimulus for bovine chromaf fin cell
catecholamine secretion (Cheek et al., 1989).

Nicotinic

receptor activation increases cation conductance through the
nicotinic receptor cation channel.

The influx of cations,

predominantly sodium, depolarizes the chromaff in cell and
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activates voltage-gated sodium and calcium channels further
depolarizing cells.

The depolarization activates additional

voltage-gated calcium channels which is followed by
increased calcium influx through these channels.

This

increased intracellular calcium then triggers catecholamine
secretion.
In addition to nicotinic and muscarinic receptor
activation, chromaffin cell catecholamine secretion can also
be induced by depolarizing concentrations of extracellular
potassium. Such depolarization immediately activates
voltage-dependent calcium channels thereby promoting calcium
influx and subsequent catecholamine secretion.

Thus,

secretion in response to extracellular K+, like nicotineinduced secretion, is dependent on extracellular calcium.
Further research with bovine chromaffin cells has indicated
that calcium influx from extracellular sources is also
essential for catecholamine secretion in response to other
known chromaffin cell secretagogues (Cheek,1991).
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B. Effects of the Catecholamines on Immune Cell Function

I. Stress and Illness

The role of stress in illness has been debated for many
years.

Although numerous observations have been documented

over the centuries which note a relationship between
stressful periods in life and subsequent illnesses,
definitive physiologic evidence of such a relationship has
been difficult to obtain since both psychological
(cognitive) and physical (non-cognitive) stimuli may
contribute to physiologic stress.

The idea that mental and

physical health are interdependent can be found in early
medicine in the works of Aristotle.

This concept was

further substantiated by Galen when he observed that
melancholic women were more likely to develop cancer than
their more confident and vital counterparts (Kort, 1994).
Similar associations between emotional stress and health
appear even in current studies.

For instance, studies cite

that job strain has a negative impact on health (Lerner et
al., 1994).

There is also evidence of a correlation between

a positive mental state and better health in terminal AIDS
patients (Kendall, 1994).
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Early in this century Hans Selye expanded this notion
of "mind-body" interaction when he noted that not only
emotional stress but also physical stress may affect
physiologic function.

Selye described how "diverse noxious

agents" produced nonspecific events that "sick people" share
in common.

Furthermore, Seyle explained that these "noxious

agents" included both harmful physical agents (i.e. viruses,
bacteria, excessive body weight) as well as how an
individual reacted to a harmful physical agent (cognitive
stimuli)

(Selye, 1936).

One of the many difficulties in ascertaining a
potential connection between stress and illness is in the
definition of "stress".

Unfortunately, as Selye would note,

there is no reliable or accurate way to experimentally
define stress or how it will affect an individual since not
only the stressor itself but also the way an individual
reacts to that stressor will effect the physiologic response
(Selye, 1975).

Typically, the term "stress" is defined in

the context of research and pathophysiology as "the
reactions of the body to forces of a deleterious nature,
infections and various abnormal states that tend to disturb
its normal physiological equilibrium (homeostasis)"
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(Burgess, 1987).

As Selye described in his early

observations, this definition requires that the reactions of
the body to physical/psychological stimuli as well as the
stimuli themselves be considered the "stress".

This is

problematic when designing experimental protocols to
determine the stress-illness relationship since both
physical and psychological parameters are involved (Selye,
1980).

Fortunately, experiments in animals as well as in

humans indicate that the mechanism behind both physiological
and psychological stress-induced dyshomeostasis may be
attributed mostly to changes in the neuroendocrine system
which modulates immune system function (Sheridan et al.
1994).

Key factors of this neuroendocrine immunomodulation

appear to be the pituitary and adrenal gland hormones,
including the catecholamines.

II. Sympathetic Innervation of Primary and Secondary
Lymphoid Organs
Investigations have demonstrated that adrenergic
modulation of the immune system may occur at the earliest
stages of the immune cell maturation process and may
potentially dictate the functional capacity of immune cell
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populations.

Anatomical studies from several laboratories

(Ackerman et al., 1987; Bellinger et al., 1988; Kendall and
Al-Shawaff, 1991; Nohr and Weihe, 1991) show that autonomic
nerve fibers, mainly noradrenergic, innervate primary,
secondary as well as mucosal associated lymphoid tissue organs which are the ultimate source of all cells of the
immune system.

These tissues include the bone marrow,

thymus, spleen, lymph nodes and gut-associated lymphoid
tissue (GALT)

Distributed into specific compartments of

these organs, these noradrenergic fibers are associated with
various cellular components of the immune system including
lymphocytes, macrophages, and mast cells (Felten and
Olschowka, 1987; Felten and Felten, 1990)
Developmental studies of the noradrenergic innervation
of lymphoid organs of the rat indicate that this
sympathetic-immune association may occur post-gestationally
and continue into adulthood (Ackerman et al., 1987; D.L.
Felten et al., 1987).

As the animals mature, however, there

appears to be an age-dependent denervation of the spleen
such that by age 27 months the total norepinephrine content
of the rat spleen diminished by approximately 50% (S.Y.
Felten et al., 1987; Bellinger et al., 1987).

While this
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diminished splenic norepinephrine content could be explained
by decreased synthesis in existing splenic nerve terminals,
further investigations indicated there was an actual
retraction and loss of noradrenergic fibers in the aging
spleen.

Interestingly, sympathetic innervation in other

organs of these aged animals, such as the heart, persisted
and circulating catecholamine actually increased with age.
The functional role of noradrenergic innervation of
lymphoid organs has yet to be fully understood.

Studies

examining central lymphoid compartments, the bone marrow and
thymus, indicate that cell proliferation, differentiation,
and emigration may be influenced by the local branches of
the sympathetic nervous system (Webber et al., 1970; Byron,
1972, Singh, 1985).

For instance, the catecholamines may

inhibit hematopoiesis via alpha-1 adrenergic receptors on
bone marrow cells (Maestroni and Conti, 1994).

The effects

of noradrenergic innervation on secondary lymphoid
compartments, although more thoroughly examined, appear
dependent on the animal model and experimental protocol.
Several early studies (Besedovsky et al., 1979; Williams et
al., 1981) suggested that the immune system was

constitutively suppressed by noradrenergic innervation of
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the secondary lymphoid organs.

Chemical or surgical

sympathectomy of the secondary lymphoid organs in these
studies led to an augmentation of immunologic functions
suchas the antibody (Besedovsky et al., 1979) and the
delayed hypersensitivity response (Braun et al., 1986)
These investigations, however, utilized neonatal mice or
rats and assessed immune cell function in these same animals
after they reached adulthood.

Interestingly, if the

sympathectomy was not performed until the animal reached
adulthood, the antibody response was either inhibited (Hall
et al., 1982) or unaffected (Miles et al., 1981).

Unlike

earlier studies, these data suggested that in the adult
animal the sympathetic nervous system maintained immune cell
function in the secondary lymphoid organs.

Although

sympathectomy of the adult animal has been shown to suppress
both T cell (Livnat, 1986; Madden et al., 1986) and B cell
(Madden et al., 1986) function, natural killer cell and
macrophage activity appears to be augmented when
noradrenergic influences are removed from lymphoid organs
(Koff et al., 1985; Madden et al., 1987).

The variability

of the noradrenergic influence on lymphoid function (i.e.
age, organ/cell type) makes it difficult to designate
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specific immunologic consequences to alterations in this
neural-immune interaction at even the earliest stages of
immune cell development.

Inunune Cell Adrenoreceptors

III.

The catecholamines exert their effects through two main
classes of adrenergic receptors, a and

~

- a subdivision

first proposed by Ahlquist (1948) to distinguish different
adrenergic responses in various organ systems.

Later

studies (Arnold et al., 1966; Lands et al., 1967; Lager,
1974) revealed there are several different subtypes of each
of these receptors, each appearing to be the product of a
distinct gene family (Summers and McMartin, 1993).

Subtypes

of the beta subclass include type-1, type-2, and more
recently the type-3 beta adrenoreceptor.

Alpha adrenergic

receptors are divided into type-1 and type-2

(Price et al.,

1994).
The second messenger systems to which the adrenergic
receptors are coupled are unique to each subtype.

However,

all sequenced adrenergic receptors have been shown to belong
to the guanine nucleotide binding protein, or G-protein,
linked superfamily of receptors (Cotecchia et al., 1990;
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Strosberg, 1991).

The a 1 -adrenoreceptor, through Gq,

stimulates phospholipase C (PLC) which initiates the
hydrolysis of

phosphatidylinositol bisphosphate (PIP 2 ) to

produce the second messengers diacylglycerol (DAG) and
inositol trisphosphate (IP 3 ) .

These second messengers are

responsible for the activation of protein kinase C (PKC) and
the liberation of calcium from intracellular stores
respectively (Berridge and Irvine, 1989) .

In contrast, the

a 2 -adrenoreceptor is coupled by Gi to adenylyl cyclase or to
ion channels.

Activation of the a 2 -receptor alters cellular

activity by reducing intracellular adenosine 3', 5' - cyclic
monophosphate (cAMP) or by directly modifying ion channel
activity (e.g. Ca 2 + or K+ channels)

(Bylund, 1988).

The 13-

adrenoreceptor subtypes are coupled through yet another G
protein, G8 ,

to the membrane bound enzyme, adenylyl cyclase.

Hence, 13-adrenergic receptor activation alters cellular
activity by increasing intracellular cAMP concentrations.

Characteristically, a receptors are more sensitive to
norepinephrine while the 13 receptor subtype is more
responsive to epinephrine stimulation (Goodman and Gilman,
1990).

Similarly, the adrenergic blocking action of many

23

compounds is also selective for each receptor type.

The

imidazolines and haloalkylamines are selective for the a
receptors whereas propranolol blocks only
(Goodman and Gilman, 1990).

~

receptors

More recently, compounds

specific to receptor subtypes have been identified.
example, salbutamol and salmeterol are specific

For

~ 2 -receptor

agonists while alpha-methylnorepinephrine stimulates the
alpha-2 adrenoreceptor alone (Felsner et al., 1995; Muller-

Wieland et al., 1994).

The unique pharmacologic properties

of these compounds make it possible to experimentally
ascertain which adrenergic receptor type(s) are responsible
for individual cellular or systemic alterations in response
to catecholamine.

Such pharmacologic agents were also

utilized to determine that cells of the immune system
possess functional

alpha and beta adrenergic receptors and

are capable of responding to catecholamine.

A. Beta Adrenergic Modulation of Immune Cell Function

The

~-adrenergic

receptor function has been well

characterized due to the availability of several high
affinity labelled antagonists.

Radioligand binding and

pharmacologic studies have confirmed the presence of the

~2 -
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adrenergic receptor on most cells of immune origin.

Cell

types expressing functional 0 2 -receptors include
granulocytes, natural killer cells, monocytes, B cells, and
T cells (Plaut, 1987).

There is some discrepancy in the

literature as to which of these cell populations have the
highest receptor density.

Some sources demonstrate the T

suppressor/cytotoxic (CDS+ phenotype) and the natural killer
cell populations as having the most 0 2 -adrenoreceptors
(Murray et al., 1992) while others the B-cell population
(Arnason, 1991) .
The immunosuppressive properties of 0 2 -receptor
activation were first demonstrated using human peripheral
blood lymphocytes (PBL) co-cultured with high concentrations
of the 0-adrenergic agonists isoproterenol and epinephrine
(25 mM) .

Culture of these cells in the presence of the 0-

agonists led to suppressed mitogen responsiveness (Hadden et
al., 1970).

Even in the presence of a low, physiologically

relevant concentrations (1-lOOnM), addition of isoproterenol
for a brief period at the initiation or the end of the
culture period resulted in depressed response to the
mitogen.

Conversely, in vitro studies demonstrated that

mitogenic stimulation led to a down-regulation of the 0-
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receptor on lymphocytes (Smith et al., 1971; Johnson et al.,
1981; Cazaux et al., 1995).

Among other actions,

~

adrenergic agonists have also been shown to suppress IL-2
production, block expression of IL-2 receptors, inhibit T
cell mediated proliferation, inhibit lymphocyte-mediated
toxicity as well as human lung mast cell function, and
depress NK cell function (Feldman et al., 1987; Plaut, 1987;
Heilig et al., 1993; Benschop et al., 1994; Chong et al.,
1995).

~ 2 -adrenoreceptor

activation has also been shown to

alter metabolic pathways in mononuclear leukocytes by
inhibiting fatty acid synthesis (Muller-Wieland et al.,
1994) .

In support of this suppressive property of the

~2 -

adrenergic receptor, experimental evidence demonstrates that
~-receptor

antagonists tend to potentiate the

immune response (Luecken and Lysle, 1992; Benschop et al.,
1993; Gentilini et al., 1994).
While a trend emerges which indicates

~-receptor

activation suppresses immune cell function, the literature
reveals this relationship is dependent on the cell
population being studied and the experimental conditions.
For instance, whereas T cytotoxic/suppressor cell function
is depressed by

~-receptor

activation, Leu 3+8+ (Th
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suppressor activator) cells responsiveness to PHA is
enhanced in the presence of isoproterenol (10 µM) while Leu
3+8-

(Th suppressor enhancer) cells are not effected (Khan

et al., 1985).

Therefore, one may not generalize that cell

mediated immunity is inhibited by
activation.

~-adrenergic

receptor

Interestingly, the humoral immune response also

may be enhanced by

~-adrenergic

receptor activation.

~2 -

adrenergic receptor activation has been shown to lead to an
enhanced antibody response (Burchiel and Melman, 1979;
Sanders and Munson, 1984a; Sanders and Munson, 1984b)
through both direct and indirect mechanisms.
Investigations are addressing the role of immune cell
~-adrenergic

receptor activation in disease states such as

juvenile type I diabetes mellitus (Schwab et al., 1993) or
schizophrenia (Bondy et al., 1984)
demonstrate a decreased
disease states.

~-receptor

These studies
responsiveness in the

This is attributed to a diminished receptor

density on the lymphocytes of diabetic children and a
decreased receptor affinity in schizophrenic patients.

In

vitro models may potentially provide some insight into the

mechanisms behind altered

~-receptor

these or other disease states.

responsiveness in

However, the literature
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clearly demonstrates that to understand the clinical
implications of disease-related diminished immune cell

~

receptor responsiveness, variables such as the cell
population(s) exhibiting the diminished response need to be
considered.

B. Alpha Adrenergic Modulation of Immune Cell Function

Pharmacologic and radioligand binding studies
demonstrate that both the a 1 - and the a 2 -adrenoreceptor are
present on cells of immune origin.

Leukocytes which have

been shown to express functional a-adrenergic receptors
include T cells (Felsner et al., 1995), monocytes (Lappin
and Whaley, 1982), neoplastic (chronic lymphocytic leukemia)
B cells (Goin et al., 1991), and neutrophils (Hulin et al.,
1985), although neutrophil expression of this receptor
subtype has recently been brought into question (Musgrave
and Seifert, 1994).

Further examination of leukocyte a-

adrenoreceptor expression reveals that this receptor may not
only differ among cell types but also may vary within a
single cell population depending on its anatomical location.
Experimental evidence demonstrates that while the alphareceptor is present on splenic lymphocytes (McPherson and
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Summers, 1982), there is no evidence that the receptors are
found on the circulating counterparts of these cells (Casale
and Laliner, 1988).
The potential role of a-adrenergic receptor in
modulation of immune cell function is just beginning to be
understood.

Several studies have employed a-adrenergic

agonists and antagonists to determine the function of this
receptor type in stress-induced immunomodulation (Hadden et
al., 1979; Sanders and Munson, 1985).

work from Hadden et al.

Some of the earliest

(1979) demonstrated that like

epinephrine, high concentrations of norepinephrine (25 mM)
in culture with human peripheral blood lymphocytes (PBL)
to an immune cell suppression.
immunosuppressive

~-receptor

led

Interestingly, unlike the

modulated response, more

physiologic concentrations of norepinephrine

(1-lOOnM)

elicited an increased mitogen responsiveness in the cultured
cells.

Similar to the epinephrine-mediated

~-response,

the

time and duration of exposure of the lymphocytes to the
norepinephrine was important.

Recent investigations show

that this a-adrenergic immunopotentiating effect of the
catecholamines may apply to the in vivo scenario as well.
Carr et al.

(1992) have demonstrated that in the mouse
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model, cold stress consistently augmented total IgG and IgM
production by splenic lymphocytes and this mediation was a
result of activation of alpha-adrenergic pathways.

However,

since splenic lymphocytes were utilized in these studies, it
is unclear which cell population(s) are responsible for this
a-receptor mediated augmentation.
Much like

~-adrenergic

receptor, a-receptor activation

not only has immunopotentiating (i.e. enhanced antibody
response) but also immunosuppressive capabilities.
Recently, Felsner et al. demonstrated that a 20h continuous
treatment of rats with catecholamine markedly suppressed the
in vitro reactivity of T lymphocytes.

Using selective

agonists, the group identified the relevant receptor to
belong to the alpha-2 subtype (Felsner et al., 1995).
Contrary to other experimental findings, Felsner and
colleagues observed this alpha-mediated suppression on T
cells isolated from peripheral blood but not in splenic T
cells.

This suggests that peripheral blood lymphocytes do

possess functional alpha-adrenoreceptors.

The suppressive

action of alpha-adrenergic receptor activation is also
prevalent when looking at metabolic pathways in mononuclear
leukocytes.

Muller-Wieland et al.

(1994) demonstrated that
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the specific alpha-2 receptor agonist alphamethylnorepinephrine, but not the alpha-1 agonist
phenylephrine, inhibited the fatty acid synthesis rate in
isolated human mononuclear cells.

C. Immunomodulation of Neuroendocrine Function

I. Immune Cell Secretion of Neuroendocrine Signalling
Molecules
A salient feature of immune system and neuroendocrine
system interactions is their capacity to communicate with
each other via common signal molecules and common receptors
(Blalock, 1994).

Central to this bidirectional

communication is production of classic neuropeptide hormones
by cells of immune origin.

The first evidence that

leukocytes could synthesize functional neuroendocrine
hormones was obtained from studies which demonstrated that
during the production of interferon alpha (IFNa), virallychallenged human leukocytes coexpressed a peptide which was
antigenically related to the pituitary hormone,
adrenocorticotropin (ACTH)

(Smith and Blalock ,1981)

This

immune-derived ACTH was similar to its pituitary counterpart
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with respect to its antigenicity, molecular weight, and
retention time on high pressure liquid chromatography
(HPLC) .

Furthermore, the leukocyte-derived ACTH could

stimulate glucocorticoid secretion from adrenal cortical
cells in vitro and, thus, was bioactive and potentially
functional

(Clarke et al., 1993).

The potential biological

relevance of this molecule was addressed in in vivo studies
using hypophysectomized mice.

Viral challenge of

hypophysectomized animals led to a significant elevation in
circulating glucocorticoids when compared to control mice
even though the classic glucocorticoid stimulant, pituitary
ACTH, was essentially eliminated.

Splenocytes of these

hypophysectomized mice also stained positive for both ACTH
and additional POMC-derived peptides, the endorphins, while
control mouse splenocytes did not (Smith et al., 1982).
Ultimately, researchers demonstrated that this leukocytederived ACTH had the same amino acid sequence as pituitaryderived ACTH and originated from the same precursor,
proopiomelanocortin (POMC), in immune cells as in the
pituitary gland (Smith et al., 1990).
While immune cell production of the POMC-peptides was
originally described in response to immunologic stimulation
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of these cells, later studies revealed that immune cells
synthesize and secrete bioactive ACTH and endorphin in
response to corticotropin releasing hormone (CRH), the
hypothalamic regulator of pituitary ACTH (Smith et al.,
1985).

Additionally, ACTH production was inhibited by the

synthetic glucocorticoid, dexamethasone, much like pituitary
cells.

Interestingly, this immune cell-derived ACTH was

also shown to suppress antibody and lymphokine production
(Johnson et al., 1982; Koff and Dunegan, 1985) thereby
potentially acting in an autocrine/paracrine manner.

Thus,

these reports served as a benchmark demonstrating that
products of the immune system could produce and respond to
functional neuroendocrine hormones.
Production of hormones by the immune system is not
limited to the POMC-derived peptides but also includes
thyrotropin (TSH)

(Smith et al., 1983), chorionic

gonadotropin (CG)

(Harbor-McMennamin et al., 1986), growth

hormone (GH) and prolactin-related peptides (Hiestand et
al., 1986), somatostatin (Lygren et al., 1984; Goetzl et
al., 1985), luteinizing hormone

(LH)

(Emanuele et al.,

1990), and vasoactive intestinal peptide (VIP)
al., 1984), among others.

(Lygren et

Experimental evidence indicates
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that similar to the POMC peptides these immune-derived
molecules may not only function to modulate neuroendocrine
function but also may serve some local immunoregulatory
function.

For example, the opioid peptides have

to stimulate NK cell activity

been shown

(Koff and Dunegan, 1985)

while GH enhances function of the cytotoxic T cell as well
as T cell colony formation (Mercola et al., 1981; Snow,
1985).

In contrast, both somatostatin and VIP suppress

immune function by inhibiting T cell proliferation (Payan et

al•

I

1986)
In general, release of the neuroendocrine signalling

molecules is positively regulated by an identified, specific
stimulus.

The hypothalamus, for example, releases CRH which

directly stimulates the pituitary to release ACTH.

In turn,

this ACTH specifically stimulates adrenal cortical
glucocorticoid secretion.

Experimental evidence has

accumulated which suggests that immune cell synthesis and
release of hormone signalling molecules also occur in
response to specific stimuli.

Most of the aforementioned

peptide hormones appear to be synthesized by leukocytes in
response to both the classic neuroendocrine regulatory
molecules and to specific immunologic stimuli.

For
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instance, TSH, the first de nova synthesized glycoprotein
hormone found in the immune system, is synthesized and
secreted by immune cells in response to the T cell mitogen
staphylococcal enterotoxin A (SEA)
thyrotropin releasing hormone (TRH)

(Smith et al., 1983) or
(Krueger et al., 1989).

In contrast, a mixed lymphocyte reaction (MLR) is the only
known stimulus for lymphocyte CG synthesis (Harbour et al.,
1986).
Potentially, this information may be important when
determining the physiologic significance of immune cell
production of these peptides as well as provide insight into
certain aspects of a pathophysiology related to an immunederived neuroendocrine hormone.

Such information has been

utilized, for example, in current models of pregnancy.
Lymphocyte-derived CG has been speculated to be an important
suppressive factor necessary for a successful implantation
of the blastocyst and, ultimately, a successful pregnancy
(Blalock, 1992). Collectively, these results suggest that
cells of the immune system should now be considered a
physiologically relevant source of neuroendocrine signalling
molecules.
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II. Non-neurogenic Modulation of Chromaffin Cell
Catecholamine Secretion
Modification of neuroendocrine function by signalling
molecules from other systems such as the immune system
extends to a variety of organs including the adrenal gland.
As stated previously, the adrenal medulla secretes
catecholamine during a typical stress response as a result
of cholinergic stimulation of medullary chromaff in cell
nicotinic and muscarinic receptors.

Chromaf fin cell

secretagogues, however, are now known to include several
additional signalling molecules.

These mediators include

but are not limited to angiotensin II

(Powis and O'Brien,

1991), bradykinin (Owen et al., 1989), histamine (Bunn and
Boyd, 1992), arachidonic acid (Negishi et al., 1990), as
well as y-aminobutyric acid (GABA)

(Gonzalez et al., 1992)

Several studies have focused on characterizing the
secretory mechanisms of each of these molecules.
Catecholamine secretion in response to most of these
secretagogues, like cholinergic catecholamine secretion, is
a calcium dependent process (O'Sullivan et al., 1989; Cheek,
1991).

The only exception appears to be a non-calcium

dependent catecholamine release observed in response to high
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concentrations (0.1-1.0mM) of histamine (Goh and Kurosawa,
1992).

Interestingly, most of these mediators also utilize

the phosphatidylinositol pathway to initiate chromaf fin cell
exocytosis.

Similar to muscarinic receptor activation, the

binding of arachidonic acid (Negishi et al., 1990),
histamine (Noble et al., 1986), bradykinin (Owen et al.,
1989), and angiotensin II (Sasakawa et al., 1989) to their
respective chromaffin cell receptor stimulates
phosphoinositide metabolism.

Breakdown of membrane inositol

phospholipids liberates the intracellular second messengers
DAG and IP 3 •

Binding of the IP 3 molecule to its

intracellular receptor, a receptor-gated channel, leads to
release of calcium from internal stores and a subsequent
intracellular calcium rise in the chromaffin cell.

This

initial increase in intracellular calcium is then followed
by an influx of calcium from external stores (Owen et al.,
1989; Negishi et al., 1990; Goh and Kurosawa, 1991; Powis
and O'Brien, 1991).

Apparently, influx of external calcium

is essential for these secretagogues to stimulate
catecholamine release since removal of extracellular calcium
abolishes catecholamine secretion in all cases (Owen et al.,
1989; Negishi et al., 1990; Goh and Kurosawa, 1991; Powis
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and O'Brien, 1991).
Although histamine, bradykinin, angiotensin II, and
arachadonic acid utilize the same second messenger system to
increase intracellular calcium and stimulate catecholamine
secretion, the efficacies of each of these chromaff in cell
secretagogues differ considerably.

Maximal histamine-

induced catecholamine secretion from chromaf fin cells is
comparable to levels seen in cholinergic stimulation (Livett
and Marley, 1986; Owen et al., 1989).

Chromaf fin cell

stimulation by angiotensin and bradykinin, however, leads to
the release of only a modest amount of catecholamine (Bonn
and Marley, 1989; Owen et al., 1989). There are potentially
several reasons for the observed differences in
catecholamine secretion in response to these secretagogues.
For example, the efficacious chromaffin cell secretagogue
histamine stimulates a prolonged, more global calcium influx
(Staudermann et al., 1990; Staudermann and Pruss, 1990;
Cheek et al., 1993) when compared to other less efficacious
secretagogues such as angiotensin II and bradykinin.

In

addition, these secretagogues appear to elicit different
patterns of second messenger formation/breakdown in these
cells (Staudermann and Pruss, 1990; Plevin and Boarder,
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1988) .

Although knowledge of these systems is limited, the

spatial and temporal variations in intracellular calcium as
well as different patterns of second messengers may be
reasons for the differences in catecholamine secreted in
response to these molecules.
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RATIONALE

Recent investigations from this laboratory provide
evidence for yet another non-neural chromaff in cell
secretagogue of immunologic origin.
have demonstrated that factor(s),

In vitro experiments

like ACTH and the

endorphins (Smith and Blalock, 1981; Smith et al., 1982),
released by immune cells may potentially act in vivo to
modulate adrenal medullary catecholamine release (Wang,
1992; Jones et al., 1993) .
these factor(s)

Preliminary data indicate that

are small molecular weight peptide(s)

(<3,000) and are present and active in a variety of species
(bovine, porcine, human) .
unidentified factor(s)

Similar to histamine, these

stimulate adrenal medullary

chromaf fin cell secretion to levels comparable to maximal
cholinergic release

(Jones et al., 1993).

The following

dissertation research was performed to further identify and
characterize these immune-derived factor(s).

Identification

and characterization of immune-derived signalling molecules
which may modulate neuroendocrine function (i.e. chromaffin
cell epinephrine secretion) will provide insight to the
potential homeostatic importance of intersystems
communication.

Results of these studies will provide a
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foundation for future studies of immunomodulation of stress
hormone release.

As mechanisms of stress-associated

immunologic changes and immune modulation of the stress
response are understood, manipulation of these systems and
improved patient outcome to stress and infectious challenge
becomes possible.

CHAPTER III

MATERIALS AND DETAILED METHODS

A. Cell Culture

I. Primary Cultures of Chromaffin Cells
a. Isolation and Culture: Chromaffin cells were

isolated from adult bovine adrenal glands according to the
overall procedure described by Dahmer et al.

(1990).

In

brief, adrenal glands were perfused with collagenase,
incubated at 37°C and medullary tissue removed for further
digestion.

Digested cells were washed, counted, viability

determined with trypan blue and purity assessed with neutral
red.

Cells were plated on collagen-coated 24-well plates at

a density of 3Xl0 5 cells per cm2 and media was changed after
the first day and then as needed to maintain a normal pH.
b. Chromaffin Cell Culture Media:

Primary cultures of

chromaffin cells were maintained 4-7 days subsequent to
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their isolation in media comprised of equal parts of F-12
Nutrient Mixture (Gibco BRL, Gaithersburg, MD) and
Dulbecco's Modified Eagle's Medium (D-MEM, Gibco BRL,
Gaithersburg, MD).

Five hundred milliliters of this media

contains 5 ml lM HEPES, 55.6 mg penicillin, 220 µl
gentamicin (50 mg/ml), 62.3 µl cytosine

~-arabinofuranoside

(Ara-C, 28 mg/ml), 53.4 µl 5-fluoro-2'-deoxyuridine (5-FDU,
24 mg/ml), and 2.76 ml Nystatin suspension (10,000
units/ml) .

Media is supplemented with fetal bovine serum

(FBS, 10% v/v) and 5.6 ml filter-sterilized L-glutamine (200
mM)

is added every thirty days.
c. In vitro Model of Catecholamine Secretion: Basic

secretion experimental protocols are those described by
Dahmer et al.

(1990).

In brief, growth media was removed

and replaced with conditioned media (0.5ml, 90 min.
incubation), serum-free RPMI-1640 (0.5ml, 90 min.
incubation), Earle's Balanced Salts Solution (EBSS, 0.5ml,
90 min.), or secretagogue in EBSS (0.5ml, 10 min.
incubation) .

After incubation, media was removed and saved.

Catecholamine content in these samples represent that
stimulated by conditioned media (CM), spontaneous/basal
secretion (RPMI/EBSS) , or that stimulated by a known
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secretagogue.

Cells were lysed by lM perchloric acid

(l.Oml) and saved to determine the remaining catecholamine
content of the cells.

The fraction of catecholamine

(epinephrine) secreted into the media as a percent of total
content was calculated by dividing the amount secreted by
the total well content.

Secretion experiments were

routinely done in triplicate using three separate wells on
any one plate which were derived from the same adrenal
gland.

Replicates of separate triplicate determinations

were made on cells from different chromaff in cell
preparations.

Cell epinephrine content (ng/10 6 cells)

ranged from 13.5±0.4 µg to 19.8±0.6 µgin all preparations.
Epinephrine was quantified by HPLC using electrochemical
detection.

Mobile phase was O.lM monochloroacetic acid with

O.SmM EDTA and l.OmM sodium octyl sulfate adjusted to pH
3.0.

Acetonitrile was added at 15ml/L.

A BAS Liquid

Chromatographic System including an LC 4C electrochemical
detector and glassy carbon electrode was used for all
analyses.
d. Data Analysis: All data are presented as epinephrine

secretion as a percent of total cell content.

Percent

secretion of each experimental and control group(s) are
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compared with every other group using an analysis of
variance (ANOVA).

A Tukey's follow-up test is utilized when

statistically significant differences are found between
groups.

A p<.05 is considered statistically significant.

II. Primary Cultures of Mononuclear Cells from Spleen
a. Isolation and Culture:

Whole bovine spleen was

obtained from a local slaughter house.

Inner spleen tissue,

which includes both red and white pulp, was dissected out,
cut into small pieces and forced through wire mesh in Hank's
Balanced Salts Solution (HBSS) at room temperature.

Crude

cell suspensions were layered on density gradient media
(Fico/Lite-LymphoH, Atlanta Biologicals), centrifuged and
then separated cells were removed and washed.

Isolated

cells were transferred to flasks with RPMI media containing
only essential amino acids and antibiotics at a density of
2Xl0 6 cells/ml.

The growth media was isolated from the

cells and either used promptly or frozen (-20°C) after at
least 24 hours of culture.

This media taken from

mononuclear cell cultures containing all factors released by
the mononuclear cell populations is referred to as
conditioned media (CM) .

Secretion experiments utilized CM
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filtered through Centricon filters

(3,000 MW cutoff) to

remove all factors greater than 3,000 MW.
b. Mononuclear Cell Culture Media:

Isolated

bovine splenocytes were maintained in serum-free RPMI-1640
(Gibco BRL, Gathersburg, MD).

Five hundred milliliters of

this medium contained 1 g NaHC0 3 ,

0.5 ml gentamicin

(50mg/ml), 5 ml Dulbecco's Modified Eagle Medium (D-MEM), 5
ml penicillin-streptomycin (5,000 units/ml penicillin; 5,000
µg/ml streptomycin), and 25 µl 2-Mercaptoethanol (2-ME, lM).
L-glutamine (5.6 ml, 200mM stock) was added to media every
thirty days.
c. Epinephrine Co-Culture:

Isolated bovine mononuclear

cells were counted and suspended in RPMI-1640 at 2X10 6
cells/ml.

Aliquots of cell suspension were then placed into

25 cm2 tissue culture flasks with or without various
concentrations of epinephrine (lnM - lµM, Sigma Chemical Co,
St. Louis, MO) and cells were allowed to incubate at 37°C
for 24 hours.

At that time, cell supernatant was harvested

and then used in secretion experiments or frozen (-20°C) for
future use.

Epinephrine (1 µM),

in the presence of the

~

adrenergic receptor antagonist, propranolol (100 µM), was
also incubated overnight with mononuclear cell cultures.
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Since epinephrine may remain unoxidized in the supernatant
of these cultures after the twenty-four hour culture period,
experiments were performed concurrently to determine the
amount of residual catecholamine.

The various

concentrations of epinephrine (1 nM - 1 µM,

in RPMI-1640)

were incubated at 37°C for 24 hours then analyzed using
HPLC.

Oxidation of epinephrine in cell cultures was

minimized by the presence of either 0.2 mg NaS0 3 /ml RPMI or
0.1% ascorbic acid.
III. Hybridoma Cell Lines
a. IL-ASl/anti CD-8:

The immortal cell line IL-ASl, a

murine hybridoma cell line producing monoclonal antibody
(IgGl) to the bovine orthologue of human CDB, was obtained
from American Type Culture Collection (ATCC, Rockville, MD).
Cells were cultured at the concentration of 10 6 cells/ml in
a media comprised of RPMI-1640 supplemented with 10% (v:v)
fetal bovine serum and 20 µM 2-Mercaptoethanol.

Cultures

were maintained by adding fresh media every 2-3 days as
needed.
b. IL-All/anti CD-4:

The immortal cell line IL-All, a

murine hybridoma cell line producing monoclonal antibody
(IgG2a) to the bovine orthologue of human CD4, was obtained
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from American Type Culture Collection (ATCC, Rockville, MD) .
Cells were cultured at the concentration of 10 6 cells/ml in
RPMI-1640 supplemented with 10% fetal bovine serum and SOµM
2-Mercaptoethanol.

Cultures were maintained by the addition

of fresh media every 2-3 days as necessary.

B. Mononuclear Cell Separation/Purification

I. Separation of Monocyte/Macrophage Populations
The monocyte/macrophage populations were isolated from
other splenocytes based on 1 hour adherence to plastic in
culture flasks at 37°C (Clarke et al., 1993).

Purity of the

monocyte/macrophage cultures was assessed using two
different staining methods.

Wright-Giemsa staining was used

to ensure no other adherent cell populations (i.e. dendritic
cells, fibroblasts) were present in the culture.

Non-

specific esterase activity, unique to monocyte/macrophage
mononuclear cells, was used to determine contamination of T
and B cell populations in adherent cell cultures.
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II. T cell/B cell Isolation and Separation Using
Monoclonal Antibodies

In 1975, Kohler and Milstein described a technique for
immortalization of B cells that produce a specific antibody.
The method involves cell fusion between a normal antibodyproducing B cell and a myeloma line, and selection of fused
cells that secrete antibody of the desired specificity
derived from the normal B cell.

Such fusion-derived

immortalized antibody-producing cells lines are referred to
as hybridomas.

Hybridomas producing monoclonal antibodies

specific to the bovine orthologues of the human CD4 and CDS
molecules were obtained from American Type Culture
Collection (Rockville, MD) and these cells were cultured
according to given protocols.
a. Isolation of Antibody from Hybridoma Cultures:
Hybridoma cultures were allowed to grow until culture media
was turbid.

The hybridoma cell culture flask was then

agitated, lysing cells and maximizing antibody concentration
in the suspension.
at 2000g at 4°C.

The cell suspension was then centrifuged

The supernatant was poured over a Proteins

A/G column, bacterial products that bind the Fe portion of
the antibody, and purified antibody was eluted from the
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column using O.lM glacial acetic acid (pH=2.0).

Absorbance

at 206 nm of column effluent was used to indicate antibody
elution.
b. Antibody Biotinylation and Coupling to Magnetic
Microbead: Antibody was conjugated with magnetic microbeads

using the avidin-biotin system.

Briefly, antibody was

dialyzed against O.lM NaHC0 3 (pH 8.4) overnight and
concentration after dialysis determined via spectrophometric
analysis using the Bradford assay.

Antibody was then

concentrated or diluted to obtain a final concentration of 1
mg/ml.

Immediately before use, 1.63 mg of NHS-LC-biotin

(Pierce, Rockford, IL) was dissolved in 1 ml of dimethyl
sulfoxide (DMSO) in a glass tube.

This mixture was

triturated and 50 µl was added to 1 ml antibody solution.
This procedure results in a biotin substitution ratio of
approximately 8:1.

The reaction was allowed to proceed at

room temperature for one hour.

The reaction mixture was

then dialyzed against 0.1 M NaHC0 3 for 48 hours.

Sodium

azide was not used since antibody labeled cells were
maintained in culture for an extended period (24-48h)
c. Magnetic-based Cell Separation:

Biotinylated

antibody, anti CD4 or anti CDS, was added to the lymphocyte
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cell suspension for 10 min to allow for adequate labeling
with antibody and unbound/excess antibody then removed by
three cold PBS washes (pH 7.4).

Biotinylated antibody,

bound to its respective cell surface marker, was coupled to
a streptavidin linked magnetic microbead during a 10 min.
incubation on ice, a reaction which occurs due to the high
affinity of streptavidin for biotin (Ka=10- 19M) .

Cells were

again washed in PBS and labeled cells passed over a magnetic
column.

In theory, all cells labeled with magnetically-

conjugated antibody will be retained on the column while any
unlabeled cells should pass through.

Labeled cells, still

bound to magnetic beads, are then be released from the
column by removing the column from the magnetic field and
washing several times in cold PBS.

These cells, still

labeled with antibody, may then be cultured according to
standard conditions.

This protocol was followed twice for

each lymphocyte preparation, one passage to separate CD4
positive lymphocytes and a second to isolate CDS positive
lymphocytes.

B cells were considered to be those

populations which were not labeled by magnetically linked
antibody and thus wash through the column.

Purity of these

cultures, as assessed using Fluorescence Activated Cell
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Sorter (FACS), was between 80% and 90%.

C. Peptide Purification and Isolation

I. G-25 Sephadex Column Gel Filtration

G-25 Sephadex beads (10 g) were combined with deionized
water at a ratio of 1 g per 2-3 ml water yielding a final
volume of approximately 30 ml and equilibrated for 8-10
hours.

This volume was placed in a 2 cm column which was

attached to a continuous perfusion pump with a loop
containing an injection valve and equilibrated with
phosphate buffered saline (PBS, pH 7.2).
(2 ml) was introduced using the loop.

Conditioned media

The molecular weight

standard Blue Dextran (MW 2X10 6 ) was totally excluded from
the beads and provided a measure of the void volume.
Potassium chromate (MW 194) totally penetrates the Sephadex
beads and was used to determine the total volume.

Fraction

collection (2 ml each) began when the void volume was eluted
and continued until the total volume was removed from the
beads.

Absorbance at 206 nm was measured as the fractions

were eluted from the column and was used to indicate the
presence of peptide.
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II. Polyacrylamide Gel Electrophoresis (PAGE)
Basic methods were similar to those described by
Schagger and van Jagow (1987).

In brief, a 20% acrylamide

separating gel was prepared containing 3.0 M Tris (pH 8.45)
and glycerol.

This was overlaid with a 10% spacer gel,

followed by a 4% stacking gel (3.0 M Tris, pH 8.45) yielding
a gel with approximate dimensions of 0.75mm X 6.5cm X 8.0cm.
A discontinuous buff er system was utilized which included a
Tris-base (pH 8.9) anionic buffer and a Tricine/Tris
cationic buffer.

Approximately 20 µg of sample was loaded

into each lane and a constant voltage was applied to the gel
(20V for 1 hour followed by lOOV for 1-1.5 hours).

The gel

was removed from the apparatus once the dye front reached
the anionic buffer-gel interface.

The gel was then stained

with Coomassie Blue or silver.

D. Intracellular Calcium Measurements in Chromaffin Cells

I. Solutions
a. Fura-2 AM:

Permeability of the fura-2 molecule is

achieved by addition of the acetoxymethyl (AM) ester group
to the molecule, which masks the negatively charged carboxyl
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groups rendering the molecule uncharged, hydrophobic, and
able to cross the cell membrane.

Once the fura-2 is

internalized, nonspecific esterases cleave the AM group thus
liberating the polycarboxylate form of the fura-2 molecule
which, due to its charge, becomes trapped in the cell.
Since AM esters are relatively insoluble in aqueous
solutions, the mild nonionic surfactant Pluronic F127 is
used as a dispersing agent.

Additionally, serum proteins

such as bovine serum albumin (BSA) , which have been shown to
improve loading efficiency possibly by acting as hydrophobic
carriers of the AM ester, may also be used to maximize
loading.

The AM ester form of fura-2 was used in all

analyses of intracellular calcium.
mg/ml) was made and then triturated.
tube, equal volumes of

A solution of BSA (1
In a plastic test

a 20% (weight:volume) solution of

Pluronic F127 in DMSO and fura-2 AM (lmM in DMSO) were
combined and vigorously mixed using the vortex.
Approximately 2ml of BSA solution was added to the tube and
contents were mixed once again.

The contents of the test

tube were then combined with additional BSA solution such
that the final solution contained lµM fura-2 AM, 0.1% BSA,
and 0.02% Pluronic F127.

The fura-2 concentration was kept
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as low as possible to reduce overloading artifacts which
include incomplete hydrolysis, compartmentalization, and
toxicity from hydrolysis by-products (i.e., formaldehyde).
b. Modified Kreb 1 s Buffer:

Solution was used in all

A Modified Kreb's Buffer

incubations and washes.

This

solution contained NaCl 7.8 g/L (135 mM), KCl 0.44 g/L (5.9
mM), CaCl 2 0.22 g/L (1.5 mM), MgC1 2 0.24 g/L (1.2 mM), HEPES
2.76 g/L (11.6 mM), and D-glucose 2.07 g/L (11.5 mM).

This

solution was used at a pH of 7.3.
c. Calcium Standard Buffer:

A Calcium Standard Buffer

was used for both in vitro and in situ calibrations.

This

buffer contained 3.728 g KCl/450 ml (110 mM), 1.046 g
MOPS/450 ml (11.1 mM), and 0.1015 g MgC1 2 /450 ml (1.1 mM)
and was titrated to a pH of 7.2 with KOH.
d. Buffer

11

A 11

:

Used in both in vitro and in situ

calibrations, Buffer "A" is a lOmM K2 EGTA solution.

This

solution was prepared by adding 3.804 g of the calcium
chelator EGTA (lOOmM) to 90 ml of Calcium Standard Buffer.
Once the EGTA was solubilized, the solution was titrated to
a pH of 7.2 with KOH and then to a final volume of 100 ml.
e. Buffer

11

B 11

:

Buffer "B", a lOmM CaEGTA solution, was

used in both in vitro and in situ calibrations.

EGTA (3.804
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g) and CaC0 3 (1.001 g) were added to 90 ml of Calcium
Standard Buffer.

This solution was then titrated to a pH of

7.2 with KOH and a final volume of 100 ml.

II. Calibrations
a. In Vitro:

Measurement of fluorescence intensities

at varying calcium concentrations under cell free conditions
was achieved using fura-2

(free acid, 1 µM)

addition to

solutions of known calcium content and measurement of each
respective fluorescence intensity.

Free calcium

concentrations were determined using the Maxchelator
program.

Fluorescence intensities were measured at

excitation wavelengths of 340 and 380 nm and an emission
wavelength of 510 nm.

The solutions were as follows:

Free Ca 2 + {nM) Buffer"A" {ml/ml)

Buffer"B" {ml/ml) FreeMg 2 +

0

1.000

0

0.64

10

0.937

0.063

0.65

50

0.748

0.252

0.70

100

0.598

0.402

0.75

200

0.427

0.573

0.81

500

0.230

0.770

0.81

1000 (lµM)

0.130

0.870

0.93

2000 (2µM)

0.070

0.930

0.97

{mM)
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Intensity readings from the dual excitation wavelengths
were obtained and divided (340/380) yielding ratio values.
These ratios for each calculated calcium concentration were
fit to a curve.

This curve was then compared to in situ

calibration results as well as experimental data.
b. In Situ:

To account for cell-specific modifications

in recorded fluorescence (i.e. intracellular buffering
capacity) as well as any variation in cell preparation, in

situ calibrations were performed at the end of each
experiment.

Briefly, cells were perfused with Buffer "A"

containing 10 µM ionomycin, an ionophore, and 4 mg/L
nigericin.

Nigericin, a hydrogen-potassium exchanger, was

used to compensate for any changes in intracellular pH due
to the action of the calcium-hydrogen exchanging ionomycin.
After 20 minutes of perfusion a fluorescence measurement was
taken and recorded as

Rmin.

At this point, the perfusing

solution was switched to Buffer "B" containing lOµM
ionomycin, 4 mg/L nigericin, and lOmM calcium chloride.

The

cells were perfused with this solution for 5-10 minutes at
which time fluorescence readings were taken.

The maximal

fluorescence ratio at the end of the perfusion was recorded
as

Rmax.

Calibration software, incorporated into the Perkin
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Elmer system utilized for these measurements, allowed for
the measurement and automatic subtraction of all
autofluorescence at both wavelengths.

III. Procedure
a. Preparation of Chromaffin Cells:

Chromaffin cells

were isolated as described previously (Cell Culture) .
Purified cells used in fura-2 analyses were plated on
collagen-coated coverslips (9X22 mm) at the same density as
those cells used in secretion protocols (3Xl0 5 cells per
cm2 )

•

Cells were maintained on coverslips in 60 mm tissue

culture dishes.

Media was changed after the first day in

these cultures and then as needed to maintain normal pH.
b. Loading Fura-2 AM:

Fura-2 AM solution (lµM) was

added to 60 mm tissue culture dishes containing chromaff in
cell coverslips and cells were incubated at room temperature
for one hour.

Dishes were covered with aluminum foil during

the incubation period to inhibit exposure to light.

Cells

were washed twice in Modified Kreb's Buffer Solution prior
to experimental use.
c. Measurement of Intracellular Calcium Concentration:

Chromaff in cell coverslips were placed in a perfusion
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apparatus which was subsequently placed in a disposable
cuvette.

Fluorescence intensity was measured using the

Perkin-Elmer LS SOB Luminescence Spectrometer and
accompanying software.
from 5 to 90 minutes.

Fluorescence scanning time ranged
A baseline calcium measurement was

obtained by fluorescence measurement for 40 to 60 seconds
prior to the addition of secretagogue or drug.
Secretagogues (2 ml) were added using a 3 ml syringe and 25
gauge needle while drugs (10µ1) were injected using a
Hamilton syringe (Hamilton Co., Reno, NE).

The system was

run via gravity feed (approximately 1 ml/min) and all
effluent was collected in a vacuum flask.
were performed at room temperature.

All experiments

Fluorescence

intensities were obtained using excitation wavelengths of
340 and 380nm and measuring emission at 510 nm.

Reported

ratios represent fluorescence intensity at 340 nm excitation
divided by that obtained with 380 nm excitation.
Intracellular calcium levels were determined by the
equation:

Rmax - R

Sb2
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Where Kd = 135nm (room temperature), Rmin and Rmax are
fluorescence ratios at zero and calcium levels which
saturate the calcium binding capacity of fura-2 AM
respectively, and Sf2/Sb2 is the ratio of excitation
efficiencies for free and bound fractions at 380nm
(Grynkiewicz, 1985). Ratioing not only results in
measurement of intracellular calcium concentrations that are
essentially independent of intracellular dye concentrations
but also off sets the complications of leakage and
photobleaching.
d. Data Analysis: Fluorescence intensity data from each

experiment were converted to calcium concentrations
utilizing a self-designed look-up table.

This look-up table

was constructed using the Grynkiewicz and other mathematical
equations and data obtained from in vitro and in situ
callibrations.

The final data are presented as the change

in intracellular calcium concentration (ordinate) of the
chromaff in cell population over time
to CM or secretagogue.

(abscissa) in response
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E. Antibody Production

I. Carrier Protein
a. Selection of Carrier Protein: The production of

antibody to concentrated peptide
of rabbits with peptide.

required the immunization

For these studies, the

concentrated peptide was conjugated with a carrier protein
to increase antigenicity.

The carrier protein that was

employed was Keyhole Limpet Hernocyanin, a large irnrnunogenic
protein obtained from Sigma Chern. Co.

(St. Louis, MO).

b. Coupling the Enriched Peptide Fraction to Carrier
Protein: Glutaraldehyde was utilized which coupled peptide

to carrier protein primarily through the N terminal alpha
amino acid of the peptide.

This procedure was described

previously and requires the mixing of the carrier protein
with the concentrated peptide followed by cross-linking with
0.3% glutaraldehyde (van Regenrnortel et al., 1988). The
peptide coupled carrier protein was then dialyzed against
borate buffer (pH 8.5) for 48h.

II. Polyvalent Antibody Production
New Zealand White rabbits were bled prior to
immunization to obtain a baseline and ensure no peptide-
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specific antibody was present in the blood prior to
immunization.

1 mg of the peptide/protein carrier complex

was dissolved in 0.05 M phosphate buffered saline (PBS) and
mixed with an equal volume of Freund's Adjuvant and injected
into each rabbit subcutaneously near the axillary lymph
nodes and intramuscularly in the hind leg.

At two week

intervals the animals were reinjected with the
peptide/protein carrier complex in adjuvant.

Following the

second such injection, the animals were bled through the
medial ear artery to obtain 5 ml of blood.

The serum was

separated and assessed for reactive antibody as described
below (ELISA) .

Antisera was also tested in a bioassay to

ensure antibody to a bioactive peptide is present.

III. Development of an ELISA

The enzyme linked immunoabsorbent assay (ELISA)

is an

important immunologic technique by which one can quantify
antigen (e.g. peptide) concentration by using an indicator
molecule (antibody) coupled covalently to an enzyme.
Antigen/peptide is quantified by determining the initial
rate at which enzyme converts a clear substrate in the
solution to a colored product.

Initially, an ELISA was
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developed to determine peptide-antibody presence in both
rabbit and mouse polyvalent antisera.

Methods are well

characterized (van Regenmortel et al, 1988) and are
described below.
Briefly, a fixed quantity of concentrated peptide was
attached to 96 well assay plates and incubated overnight at
4°C in phosphate buffered saline (PBS) at pH 7.2.

Once the

concentrated peptide was attached to the wells, the plastic
plates were washed with PBS containing 0.05% Tween-20.

The

remaining active sites were blocked with 0.05% gelatin
(Sigma Chem. Co., St. Louis, MO) for 2 hours at room
temperature and wells washed again with PBS containing 0.05%
Tween-20.

Serial dilutions of antibody were prepared and

incubated with a fixed amount of polyvalent antisera in the
coated plastic wells overnight at 4° C.

Wells were then

washed at least three times with PBS containing 0.05% Tween20.

To measure the amount of specifically bound polyvalent

antisera, each well was incubated with peroxidase coupled
secondary antibody for 2 hr at 37°C

(in this case a goat

anti-rabbit secondary antibody, Accurate Chem. Corp.,
Westbury, NY).

The plastic wells were then washed at least

three times with PBS containing 0.05% Tween-20.

3,3'-
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Diaminobenzidine tetrahydrochloride (DAB, 0.5 mg/ml), the
enzyme substrate, was combined with PBS (pH=7.2) containing
0.3% H2 0 2 then lOOµL of this solution was placed in each
well and allowed to incubate for 1-3 hours at 37° C.
Positive results, i.e. antibody binding specifically to
peptide sequence, were indicated by a color change in the
corresponding well.

The intensity of the color would then

be indicative of the amount of peptide bound in each well.
Since the conversion of the chromagen, DAB, yields the color
brown in a positive test, all plates were scanned at 492 nm
absorbance to determine relevant peptide concentrations in
each well.

CHAPTER IV

SIGNAL TRANSDUCTION AND THE IMMUNE-DERIVED PEPTIDE:
THE ROLE OF CALCIUM IN SECRETION

A. Introduction

The importance of stress in the etiology and prevention
of disease is becoming increasingly apparent as the
mechanics of stress-induced dyshomeostasis are understood.
Extensive documentation demonstrates that humans can respond
to both cognitive and non-cognitive stimuli through a stress
response that results in the release of the stress hormone
epinephrine into the circulation.

This increased plasma

epinephrine has a wide array of physiologic effects ranging
from substrate mobilization supporting the hypermetabolism
of fever to increased cardiovascular function.
Interestingly, recent documentation indicates that
epinephrine also may modify various immune cell functions
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thus potentially altering the immune response in times of
stress (Sanders and Munson, 1985; Feldman et al., 1987;
Plaut, 1987; Heilig et al., 1993).

Typically, adrenal

medullary release of epinephrine is attributed to neural
stimulation of adrenal medullary chromaffin cells.

Recent

studies from this and other laboratories, however, indicate
that medullary epinephrine release may also be mediated
through a non-neural mechanism (Seidler and Mills, 1989;
Zhou and Jones, 1993).

Further experimental evidence

indicates that one source of this regulation potentially
lies in the immune system (Jones et al., 1993).

Primary

cultures of mononuclear cells from bovine, porcine and human
sources have been shown to release a small (MW< 3,000)
peptide which stimulates medullary epinephrine secretion to
levels comparable to maximal cholinergic stimulation.
Although knowledge of the exact mechanism of chromaffin
cell exocytosis is poorly understood, one common feature of
all models is that catecholamine secretion is dependent on
an increase in intracellular calcium.

Initial reports

documented that a rise in intracellular calcium is a
sufficient stimulus to trigger chromaff in cell exocytosis
(Dunn and Holz, 1983).

Later studies employed the use of
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calcium sensitive fluorescent dyes (e.g. fura-2)

to

temporally and spatially resolve the relationship between
increased intracellular calcium and exocytosis (Kirn and
Westhead, 1989; O'Sullivan and Burgoyne, 1989; Cheek et al.,
1989; Stauderrnan et al., 1990).

Ultimately, investigations

revealed that chrornaf fin cell secretion in response to known
secretagogues, both cholinergic and non-cholinergic
mediators, is a calcium dependent process (O'Sullivan et
al., 1989; Cheek, 1991). The goal of the current study was

to assess the basic signal transduction mechanism of this
immune-derived peptide in chrornaffin cell catecholamine
secretion and to determine if the mechanism was similar to
other known secretagogues.

Central to this goal was

elucidating the role of calcium in peptide-induced
excitation-secretion coupling.
Multiple studies have documented the fact that adrenal
rnedullary chrornaff in cells secrete catecholamine in response
to a rise in cytosolic calcium concentration ( [Ca 2 +]
and Thastrup, 1989;

J

(Cheek

O'Sullivan and Burgoyne, 1989;

Stauderrnan et al, 1990).

This rise in intracellular calcium

can result from calcium influx, release of calcium from
internal stores, or a combination of both. Bovine chrornaffin
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cells, the model system used in these experiments, appear to
require the influx of extracellular calcium to induce
catecholamine secretion since muscarinic agonists, coupled
solely to internal calcium release, are ineffective
secretagogues.

Utilizing purified fractions of immune-

derived peptide, experiments were conducted using nonspecific as well as specific calcium channel blockers to
determine if peptide-induced secretion was, indeed,
dependent on calcium and, if so, to determine the importance
of extracellular and/or intracellular stores.

Further

experiments were performed using the fluorescent calcium
indicator, fura-2, to temporally resolve internal
oscillations in calcium in response to immune-derived
peptide stimulation.
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B. Materials and Methods

Primary Cultures of Chromaffin Cells
a. Isolation and Culture: Adult bovine adrenal glands

were used for chromaf fin cell isolation according to the
overall procedure described by Dahmer et al.,

(1990).

In

brief, adrenal glands were perfused with collagenase,
incubated at 37°C and medullary tissue removed for further
digestion.

Digested cells were washed, counted, viability

determined with trypan blue and purity assessed with neutral
red.

Cells were plated on collagen-coated 24-well plates at

a density of 3Xl0 5 cells per cm 2 and media was changed after
the first day and then as needed to maintain a normal pH.
b. In vitro Model of Catecholamine Secretion: Basic

secretion experimental protocols are those described by
Dahmer et al.,

(1990).

In brief, growth media was removed

and replaced with conditioned media (90 min. incubation),
serum-free RPMI-1640

(90 min. incubation), Earle's Balanced

Salts Solution (EBSS, 90 min.), or secretagogue in EBSS (10
min. incubation).
saved.

After incubation, media was removed and

Catecholamine content in these samples represent

that stimulated by conditioned media (CM) , basal secretion
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experiments), or that stimulated by a known secretagogue.
Cells were lysed by lM perchloric acid and acid saved to
determine the remaining catecholamine content of the cells.
The fraction of epinephrine secreted into the media as a
percent of total content was calculated by dividing the
amount secreted by the total well content.

Secretion

experiments were routinely done in triplicate using three
separate wells on any one plate which were derived from the
same adrenal gland.

Replicates of separate triplicate

determinations were made on cells from different chromaff in
cell preparations.

Catecholamines were quantified by HPLC

using electrochemical detection.

Mobile phase was O.lM

monochloroacetic acid with O.SmM EDTA and 1.0mM sodium octyl
sulfate adjusted to pH 3.0.
15ml/L.

Acetonitrile was added at

A BAS Liquid Chromatographic System including an LC

4C electrochemical detector and glassy carbon electrode was
used for all analyses.
Primary Cultures of Mononuclear Cells from Spleen

Isolation and Culture:

Whole bovine spleen was

obtained from a local slaughter house.

Inner spleen tissue,

which includes both red and white pulp, was dissected out,
cut into small pieces and forced through wire mesh in Hank's
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Balanced Salts Solution (HBSS) at room temperature.

Crude

cell suspensions were layered on density gradient media
(Fico/Lite-LymphoH, Atlanta Biologicals) , centrifuged and
then separated cells were removed and washed.

Isolated

cells were transferred to flasks with RPMI media containing
only essential amino acids and antibiotics at a density of
2Xl0 6 cells/ml.

The growth media was isolated from the

cells and either used promptly or frozen (-20°C) after at
least 24 hours of culture.
Data Analysis

All data are presented as epinephrine secretion as a
percent of total cell content.

Percent secretion of each

experimental and control group(s) are compared with every
other group using an ANOVA.

A Tukey's follow-up test is

utilized when statistically significant differences are
found between groups.

A p<0.05 is considered statistically

significant.
Intracellular Calcium Measurements in Chromaffin Cells

The calcium sensitive fluorescent dye, fura-2, was
utilized to temporally resolve changes in intracellular
calcium concentrations in response to CM-peptide.

Peptide-

stimulated alterations in intracell calcium were measured in
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the presence and absence of non-specific calcium channel
blockers to determine relative amounts of calcium influx as
well as release from internal stores.
a. Preparation of Chromaffin Cells:

Chromaffin cells

were isolated as described previously (Cell Culture) .
Purified cells used in fura-2 analyses were plated on
collagen-coated coverslips (9X22 mm) at the same density as
those cells used in secretion protocols (3X10 5 cells per
cm2 )

•

Cells were maintained on coverslips in 60 mm tissue

culture dishes.

Media was changed after the first day in

these cultures and then as needed to maintain normal pH.
b. Loading Fura-2 AM:

Fura-2 AM solution (lµM) was

added to 60 mm tissue culture dishes containing chromaffin
cell coverslips and cells were incubated at room temperature
for one hour.

Dishes were covered with aluminum foil during

the incubation period to inhibit exposure to light.

Cells

were washed twice in Modified Kreb's Buffer Solution prior
to experimental use.
c. Measurement of Intracellular Calcium Concentration:

Chromaff in cell coverslips were placed in a perfusion
apparatus which was subsequently placed in a disposable
cuvette.

Fluorescence intensity was measured using the
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Perkin-Elmer LS SOB Luminescence Spectrometer and
accompanying software.
from 5 to 90 minutes.

Fluorescence scanning time ranged
A baseline calcium measurement was

obtained by fluorescence measurement for 40 to 60 seconds
prior to the addition of secretagogue or drug.
Secretagogues (2 ml) were added to the perfusion apparatus
using a 3 ml syringe and 25 gauge needle while drugs (10µ1)
were injected using a Hamilton syringe (Hamilton Co., Reno,
NE) .

All experiments were performed at room temperature

(23°C)

Fluorescence intensities were obtained using

excitation wavelengths of 340 and 380nm and measuring
emission at 510 nm.

Reported ratios represent fluorescence

intensity at 340 nm excitation/ that obtained with 380 nm
excitation.
Intracellular calcium levels were determined by the
equation:

Rmax - R

Where Kd

=

Sb2

135nm (room temperature), Rmin and Rmax are

fluorescence ratios at zero and calcium levels which
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saturate the calcium binding capacity of fura-2 AM
respectively, and Sf2/Sb2 is the ratio of excitation
efficiencies for free and bound fractions at 380nm
(Grynkiewicz, 1985). Ratioing not only results in
measurement of intracellular calcium concentrations that are
essentially independent of intracellular dye concentrations
but also off sets the complications of leakage and
photobleaching.
Data Analysis

Fluorescence data from each experiment were converted
to the appropriate calcium concentration utilizing a selfdesigned look-up table.

This look-up table was constructed

using the Grynkiewicz and other mathematical equations and
data obtained from in vitro and in situ calibrations.
final data are presented as the change in intracellular
calcium concentration (ordinate) of the chromaffin cell
population over time (abscissa) in response to CM or
secretagogue.

The
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C. Results

Extracellular Calcium is Essential for Conditioned MediaInduced Secretion.

Extracellular calcium influx in response to peptide
stimulation was inhibited by the non-specific calcium
channel blocker cobalt (CoC1 21 2mM) .

As can be seen in

figure 1, the channel blocker completely inhibited
catecholamine secretion in response to conditioned media
indicating that peptide-induced secretion requires the
influx of extracellular calcium
Blockers of voltage-gated calcium channels do not completely
inhibit secretion in response to peptide.

Since bovine chromaffin cells contain the L, P, Q, and
N-type voltage-gated calcium channels (Lopez et al., 1989;
Lopez et al., 1994), specific blockers of these channels
were used to asses the role of each channel type in peptideinduced calcium influx.
blockers, verapamil (lµM)

Both the L- and P-type channel
and w-Agatoxin VIA (lOOnM),

significantly inhibited secretion in response to peptide.
The N- and Q-type channel blockers, w-Conotoxins GVIA (lµM)
and MVIIC (3µM)

respectively, did not effect peptide-induced
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Figure 1. Extracellular calcium dependence of conditioned
media (CM) induced secretion. Values are mean ± SEM. RPMI1640 group represents basal chromaffin cell secretion.
Triplicate determinations for all groups were made in each
of 2 chromaffin cell preparations (n=6).
*** = p<0.001
compared to CM alone using an ANOVA followed by Tukey's
comparisons.
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Media (CM)

CM +
Verapamil
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Figure 2. Effect of voltage-gated calcium channel blockers
on conditioned media (CM)-induced secretion. Concentration
of drug used are: verapamil (lµM), w-agatoxin VIA (lOOnM),
w-conotoxin GVIA (lµM) , and w-conotoxin MVIIC (3µM) . Values
are mean ± SEM. RPMI-1640, basal chromaffin cell secretion,
was 2-5% total cell content. Triplicate determinations for
all groups were made in each of 3 chromaf fin cell
preparations (n=9).
*=p<0.05 and*** = p<0.001 respectively
compared to CM alone using an ANOVA followed by Tukey's
comparisons.
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Figure 3. Effect of non-specific and L-type calcium channel
blockers on secretion in response to the nicotinic agonist
dimethyl phenyl piperazinium (DMPP) . Values are mean ± SEM.
RPMI-1640 represents basal chromaffin cell secretion. Two
triplicate determinations for all groups were made in 1
chromaffin cell preparation
(n=6).
*** = p<0.001 compared
to all other groups using an ANOVA followed by Tukey's
comparisons.
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secretion (figure 2) .

The effect of non-specific and L-type

calcium channel blockers on secretion in response to the
nicotine agonist dimethyl phenylpiperazinium (DMPP, lOµM)
can be seen in figure 3.
Removal of Intracellular Calcium Sources does not Alter
Peptide-Induced Secretion.

The effect of removal of intracellular calcium stores
on peptide-induced secretion was tested using dantrolene
(30-SOµM),

a membrane-permeable drug which inhibits

intracellular calcium mobilization, and thapsigargin (0.1lµM) , a pharmacologic agent which depletes internal calcium
stores.

As a control, the muscarinic agonist, methacholine,

was used to stimulate fura-2 loaded chromaffin cells in the
presence and absence of dantrolene or thapsigargin.

Both

dantrolene and thapsigargin completely inhibited the rise in
intracellular calcium in response to methacholine.
Conditioned media-induced secretion, however, was unaffected
by either dantrolene or thapsigargin treatment (figure 4)
indicating calcium release from intracellular stores is not
essential for peptide induced secretion.

79

s::

·-....
0

Q)
~

(.)

'S
2s::
0

u
u

·- Q)

CZl
Q)

s::
~

Q)

0... ~

Q)

·-

s:: ~

0...

~

'$.

5

0
Conditioned
Media(CM)

CM+
Dantrolene

CM+
Thapsigargin

Figure 4. Effect of removal of intracellular calcium on
conditioned media (CM) induced secretion. Values are mean ±
SEM.
RPMI-1640, basal chromaffin cell secretion, was 2-5%
in all experiments. Triplicate determinations for all
groups were made in each of 2 chromaf fin cell preparation
(n=6).
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Figure 5. Rise in intracellular calcium in response to
conditioned media (CM) stimulation is biphasic. Increased
fluorescence ratio (F340nm:F380nm) indicates an increase in
intracellular calcium. CM-stimulated increase in
intracellular calcium includes an initial, fast calcium peak
and a second, slow, sustained rise in calcium. Similar
results were obtained in other experiments.
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Figure 6. Time course of conditioned media induced
secretion. Values are mean ± SEM. Basal secretion (RPMI1640) was subtracted from each of the time points. Two
triplicate determinations were made using one chromaff in
cell preparation (n=6). Similar results were obtained on
other chromaffin cell preparations.
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Rise in intracellular calcium in response to peptide is
biphasic.

Using the membrane-permeable, fluorescent calcium
indicator, fura-2 AM, changes in chromaffin cell
intracellular calcium in response to conditioned media
peptide were recorded over a sixty minute period.

Figure 5

demonstrates that CM produces an initial calcium spike
followed by a slower, long term elevation in intracellular
calcium levels.

The biphasic nature of the intracellular

calcium response to CM stimulation correlates temporally
with the time course of conditioned media-induced secretion
(figure 6) .
Both intracellular and extracellular calcium are components
of peptide-induced internal calcium rise.

Fura 2-AM loaded chromaffin cells were stimulated with
conditioned media in the presence or absence of the nonspecific calcium channel blockers cadmium (0.5mM) or cobalt
(2.0mM).

While the initial calcium spike was blunted and

the long-term calcium increase abolished, there was still a
significant increase in intracellular calcium in response to
conditioned media (figures 7 & 8).

Conversely, the initial

intracellular calcium spike is significantly blunted in
chromaffin cells incubated with thapsigargin prior to
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chromaff in cells incubated with thapsigargin prior to
stimulation with CM (figure 9).

Taken together, these

results indicate that CM-peptide induced secretion
stimulates both calcium influx as well as calcium release
from internal stores.
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Figure 7. Cadmium blocks secondary, long term intracellular
calcium increase in response to conditioned media (CM)
stimulation. The trace is taken from the first 5 minutes of
a 60 minute time period. No change occurred in
intracellular calcium between 5 and 60 minutes. An increase
in fluorescence intensity (ratio of F340nm:F380nm) indicates
an increase in intracellular calcium.
Compared to CM alone,
cadmium attenuates the initial, fast calcium peak and
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Figure 8. Cobalt blocks secondary, long term intracellular
calcium increase in response to conditioned media (CM)
stimulation. The trace is taken from the first 5 minutes
of a 60 minute time period. No change occurred in
intracellular calcium between 5 and 60 minutes. An increase
in fluorescence intensity (ratio of F340nm:F380nm) indicates
an increase in intracellular calcium. Similar to cadmium,
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Similar results were obtained in other experiments.
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Figure 9. Thapsigargin pretreatment blunts initial
intracellular calcium spike.
The trace is of the first 3
minutes of a 60 minute time period. No change occurred in
intracellular calcium between 5 and 60 minutes. An increase
in fluorescence intensity (ratio of F340nm:F380nm) indicates
an increase in intracellular calcium. The initial calcium
spike was significantly inhibited after thapsigargin
pretreatment. Similar results were obtained in other
experiments.
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D. Discussion

Studies have demonstrated that chromaf fin cells secrete
catecholamine in response to a rise in cytosolic calcium
concentration (Cheek and Thastrup, 1989; Cheek et al.,
1990).

This can result from an influx of extracellular

calcium, release from intracellular stores, or a combination
of both.

For example, nicotinic agonists induce chromaffin

cell depolarization which leads to the opening of voltagegated calcium channels and subsequent calcium influx.
Conversely, muscarinic agonists stimulate phosphoinositide
metabolism which induces rapid accumulation of inositol
phosphates that stimulate calcium release from intracellular
stores.

Finally, known peptide secretagogues (i.e.

bradykinin, angiotensin II) stimulate chromaffin cell
secretion via both extracellular calcium influx and inositol
phosphate-activated intracellular calcium release.

The goal

of the present study was to determine if secretion in
response to a novel, mononuclear cell-derived peptide was,
indeed, dependent on calcium and, if so, to determine the
importance of extracellular and/or intracellular stores.
Initial studies addressed the role of extracellular
calcium in peptide-induced secretion.

Several inorganic
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ions (e.g. Cd 2 +, Co 2 +, La 3 +) have been reported to block the
various types of calcium channels.

Evidence indicates that

the binding site of these ions involves conserved glutamate
residues in the proposed pore of the calcium channel
(Hagiwara, 1981).

In the present study, inhibition of

calcium influx via one of these non-specific channel
blockers (Co 2 +) abolished conditioned media peptide-induced
secretion (figure 1) indicating that extracellular calcium
was essential for secretion in response to peptide
stimulation.

Further experiments were performed to assess

the role of the voltage-gated calcium channels in peptideinduced secretion.

Bovine chromaffin cells have been

reported to contain the L-, P-, Q-, and N-type voltage gated
calcium channels (Lopez et al., 1989; Lopez et al., 1994)
These channels range from high conductance (22-28pS)
channels which inactivate rather slowly (>500 msec time
constant)

(e.g.,

the L-type calcium channel) to channels of

lesser conductance (12-22pS) whose inactivation time
constants are rather rapid (50-100 msec)
and Q-type channels) .

(e.g.,

the P-, N-,

Specific blockers of these channel

types were utilized to determine the relative importance of
each channel type.

While the L- and P-type channel blockers
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(i.e. verapamil and w-Agatoxin VIA) significantly inhibited
peptide-induced secretion, the Q- and N-type calcium channel
blockers (i.e. w-Conotoxins GVIA and MVIIC) had no
significant effect (figure 2).

These results indicate that

both the L- and P-type channel are involved in calcium
influx in response to peptide but are not the only channels
through which peptide-stimulated influx occurs.

One

potential mechanism by which these voltage gated channels
are activated may be by depolarizing concentrations of
calcium directly adjacent to the L- and P-type channnels.
Upon stimulation, chromaffin cell intracellular calcium has
been shown to range from 300-1000 nM when measuring whole
cell calcium content.

It is estimated, however, that near

the plasma membrane (near the voltage gated calcium
channels) , local calcium concentrations reach 10-lOOµM potentially great enought to lead to a local depolarization
and activation of L- and P-type channels.

Alternate

pathways responsible for the additional calcium influx
include IP 3 /IP 4 gated calcium channel(s), G-protein gated
channel(s), a receptor gated calcium channel, or,
potentially, activation of IcRAc (Calcium Release Activated
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Calcium current)

in response to emptying of intracellular

stores.
Although these data do not agree with recent reports
(Lopez et al., 1994) which indicate that Q- and L-type
channels are the predominant calcium channels involved in
bovine chromaffin cell secretion, they are not surprising.
First, the time course of CM-induced secretion (90 minutes)
is obviously much longer than the time constants of
inactivation for these voltage gated channels indicating a
role for other channel types.
performed by Lopez et al.

Furthermore, studies

(1994) utilized depolarizing

concentrations of potassium to stimulate chromaff in cell
secretion.

Secretion in the present study, however,

response to a mononuclear cell-derived peptide.

is in

Whereas the

L-type channel blockers, such as verapamil, are well
documented inhibitors of catecholamine release in response
to high K+ (Boarder et al., 1987; Fonteriz et al., 1987),
secretion in response to known chromaff in cell peptide
secretagogues such as bradykinin have been shown to be
unaffected by the presence of L-type calcium channel
blockers (Owen et al., 1989).

The difference between high

K+ and bradykinin sensitivity to L-channel blockers indicate
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that these agents stimulate calcium entry via separate
routes (i.e.,

IP 3 /IP 4 gated, receptor gated, or G-protein

gated channels or IcRAc) .

Potentially, the immune-derived

peptide in this study stimulates calcium influx through nonL-type calcium channels similar to bradykinin.
The role of intracellular calcium stores in peptideinduced secretion was addressed in these studies via the use
of two pharmacologic agents - dantrolene, which blocks
calcium release from internal stores, and thapsigargin,
which depletes intracellular calcium stores.

Neither

dantrolene nor thapsigargin altered chromaffin cell
epinephrine secretion in response to peptide (figure 4) .
Although these results indicate that intracellular calcium
is not essential for peptide-induced secretion, they do not
exclude the release of calcium from these internal stores in
response to peptide stimulation.
Further studies are presented which utilized the
ratiometric fluorescent calcium dye, fura-2 AM, to
temporally resolve the intracellular calcium rise in
response to peptide.

The kinetics of intracellular calcium

changes as well as epinephrine secretion in response to
peptide stimulation was shown to be biphasic in nature
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(figures 5 & 6) similar to the potent chromaffin cell
secretagogue, histamine.

Both antagonist and

desensitization studies confirm, however, that the
stimulatory effect of conditioned media cannot be attributed
solely to histamine.
µM,

While pretreatment with histamine (100

10 min.) did not effect CM-induced secretion from the

same chromaffin cells, chromaffin cell histamine
desensitization significantly inhibitted secretion in
response to a second challenge with histamine (CM=l9.2±0.3,
CM/histamine pretreatment=lB.4±0.7, histamine=lS.5±0.9,
histamine/histamine pretreatment=2.4±0.2***, basal
secretion=l.6±0.2; ***=p<0.001 vs histamine/no
pretreatment).
Evidence is also presented in this study which
demonstrates the non-specific calcium channel blockers Co 2 +
(2.0rnM) and Cd 2 + (O.SmM) used in conjunction with
conditioned media diminish the initial calcium peak and
completely abolished the delayed, maintained rise in
intracellular calcium (figures 7 & 8).

Conversely, the

initial calcium spike in response to conditioned media was
signf icantly reduced in chromaff in cells incubated with
thapsigargin prior to stimulation with CM (figure 9).

These
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data indicate that while the secondary, maintained calcium
elevation is due solely to extracellular influx, the initial
calcium peak can be attributed to both calcium influx and
release from internal stores. Calcium release from internal
stores as well as influx from the extracellular environment
in response to conditioned media peptide is
characteristically similar to catecholamine secretion in
response to other known peptides (e.g. bradykinin,
angiotensin II, etc).
In summary, the data obtained in these studies strongly
support current concepts of epinephrine secretion in
response to peptide secretagogues from bovine chromaff in
cells.

Conditioned media peptide-induced secretion appears

to utilize calcium regulated signal transduction mechanisms
that are analogous to other known peptide secretagogues.
Similar to bradykinin and angiotensin II (Owen et al., 1988;
Plevin and Boarder, 1988), the peptide in the present study
appears to stimulate both release of calcium from internal
stores as well as extracellular influx.

The dependence on

extracellular calcium for secretion is common to both the
conditioned media peptide and other peptide secretagogues.
Additionally, the biphasic, maintained rise in intracellular

94

calcium in response to conditioned media peptide and the
efficacious stimulatory effect of conditioned media peptide
agree with studies which show that the more efficacious
chromaffin cell secretagogues (e.g. histamine) stimulate
long-term increases in intracellular calcium (Noble et al.,
1988; Goh and Kurosawa, 1991).

CHAPTER V

MONONUCLEAR CELL ORIGIN OF A NOVEL PEPTIDE
MEDIATING PERIPHERAL EPINEPHRINE SECRETION

A. Introduction

The role of stress in illness has been debated for many
years.

Although numerous observations have been documented

over the centuries which note a relationship between
stressful periods in life and subsequent illnesses,
definitive physiologic evidence of such a relationship has
been difficult to obtain since both psychological
(cognitive) and physical (non-cognitive) stimuli may
contribute to physiologic stress.

The idea that mental and

physical health are interdependent can be found in early
medicine in the works of Aristotle.

This concept was

further promoted by Galen when he observed that melancholic
women were more likely to develop cancer than there more
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confident and vital counterparts (Kort, 1994).

Similar

associations between emotional stress and health appear even
in current studies.

For instance, studies site that

job

strain has a negative impact on health (Lerner et al.,
1994).

There is also evidence of a correlation between a

positive mental state and better health in terminal AIDS
patients (Kendall, 1994).
One of the many difficulties in ascertaining a
physiologic connection between stress and illness is in the
definition of "stress".

The term "stress" is defined in the

context of research and pathophysiology as "the reactions of
the body to forces of a deleterious nature, infections and
various abnormal states that tend to disturb its normal
physiological equilibrium (homeostasis)"

(Burgess, 1987).

This definition requires that not only the reactions of the
body to physical/psychological stimuli but also the stimuli
themselves be considered the "stress".

This is problematic

when designing experimental protocols to determine the
stress-illness relationship since both physical and
psychological parameters are involved (Selye, 1980).
Fortunately, experiments in animals as well as in humans
indicate that one of the prominent underlying causes of both
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dyshomeostasis is changes in the neuroendocrine system which
modulates immune system function (Sheridan et al., 1994).
Key factors of this neuroendocrine immunomodulation appear
to be the pituitary and adrenal gland hormones, including
the catecholamines.
The catecholamines, epinephrine (released mainly from
the adrenal medulla) and norepinephrine (released mainly
from sympathetic nerve terminals) , are pivotal regulators of
many physiological events in man.

Documented actions of

the catecholamines include the aforementioned modulation of
immune function, a cardiac excitatory action, metabolic
actions, and peripheral actions specific to certain muscle
groups.

In 1929, Sir Walter Cannon first associated various

physiologic changes with increased circulating catecholamine
(largely epinephrine) in his discussion of the "fight or
flight'' response (Cannon, 1929).

This reaction occurs when

animals, including man, perceive danger (cognitive stimuli)
and prepares the animal to respond through either direct
conflict ("fight") or escape ("flight") .

However, it is

clear that stimuli not recognized directly by the central
and peripheral nervous systems and for which there is no
conscious perception also may lead to increased circulating
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catecholamine and subsequent associated physiologic changes.
Such stimuli are referred to as non-cognitive stimuli and
include bacteria, tumors, viruses, and antigens.
Although there are many potential mediators, the exact
mechanism by which non-cognitive factors modulate
neuroendocrine functions such as catecholamine release is
not yet clear.

Hypothalamic-pituitary-adrenal axis

activation occurs as a central response to non-neurogenic
mediators.

Equally important may be peripheral release of

stress hormone in response to a local non-cognitive stimuli.
Recent investigations provide evidence of one potential
mechanism by which tumors, bacteria, etc, may elicit the
release of the stress hormone epinephrine through
immunologic mediators.

An immune-derived peptide (MW<3,000)

released from mononuclear cell populations has been shown to
stimulate adrenal medullary chromaff in cell epinephrine
secretion to levels comparable to maximal neural
stimulation.

The exact mononuclear cell source of this

peptide, however, has yet to be determined.

The present

study was performed to determine which mononuclear cells may
potentially release bioactive peptide.

Such information may

provide insight as to the potential role of this peptide and
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subsequent irnrnune-neuroendocrine interactions in both health
and disease.
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B. Materials and Methods

Primary Cultures of Chromaffin Cells
Isolation and Culture: Adult bovine adrenal glands were

used for chromaff in cell isolation according to the overall
procedure described by Dahmer et al.,

(1990).

In brief,

adrenal glands were perfused with collagenase, incubated at
37°C and medullary tissue removed for further digestion.
Digested cells were washed, counted, and viability
determined with trypan blue staining.

Purity was assessed

using neutral red as described by Role and Perlman (1980)
Cells were plated on collagen-coated 24-well plates at a
density of 3Xl0 5 cells per cm2 and media was changed after
the first day and then as needed to maintain a normal pH.
In vitro Model of Catecholamine Secretion: Basic

secretion experiments are similar to those described by
Dahmer et al.,

(1990).

In brief, growth media was removed

from each well and replaced with conditioned media, serumfree RPMI-1640, Earle's Balanced Salts Solution (EBSS), or
secretagogue in EBSS.
and saved.

After incubation, media was removed

Catecholamine content in these samples represent

that stimulated by conditioned media (90 minute incubation),
spontaneous/basal secretion (RPMI/EBSS, 90 minute
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incubation) , or that stimulated by a known secretagogue
(DMPP/55mM K+, 10 minute incubation) in the presence or
absence of drug/channel blocker.

Cells were then lysed by

adding lM perchloric acid and the acid saved for
determination of
content.

the remaining cellular epinephrine

Epinephrine secreted into the media as a percent

of total content was calculated by dividing the amount
secreted by the total well content.

Secretion experiments

were routinely done in triplicate using three separate wells
on any one plate all of which were derived from the same
adrenal gland.

Replicates of separate triplicate

determinations were made on cells from different chromaff in
cell preparations.

Analysis of epinephrine was accomplished

with HPLC using electrochemical detection.

Mobile phase

contained O.lM monochloroacetic acid with O.SmM EDTA and
l.OmM sodium octyl sulfate adjusted to pH 3.0.
was added at 15ml/L.

Acetonitrile

A BAS Liquid Chromatography System

including an LC 4C amperometric detector and glassy carbon
electrode was used in all analyses.
Primary Cultures of Mononuclear Cells from Spleen
Isolation and Culture:

Whole bovine spleen was

obtained from a local slaughter house.

Inner spleen tissue,
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which includes both red and white pulp, was dissected out,
cut into small pieces and forced through wire mesh in Hank's
Balanced Salts Solution (HBSS) at room temperature.

Crude

cell suspensions were layered on density gradient media
(Fico/Lite-LymphoH, Atlanta Biologicals) , centrifuged and
then separated.

Isolated cells were washed, viability

assessed using Trypan Blue, and cells were then transferred
to flasks with RPMI media containing only essential amino
acids and antibiotics.

The growth media was isolated from

the cells after at least 24 hours of culture and either used
promptly or frozen (-20°C).
Separation of Monocyte/Macrophage Populations: The

monocyte/macrophage populations were isolated from other
splenocytes based on 1 hour adherence to plastic in culture
flasks at 37°C (Clarke et al., 1993).

Purity of the

monocyte/macrophage cultures was assessed using two
different staining methods.

Wright-Giemsa staining was used

to ensure no other adherent cell populations (i.e. dendritic
cells, fibroblasts) were present in the culture.

Non-

specific esterase activity, unique to monocyte/macrophage
mononuclear cells, was used to determine contamination of T
and B cell populations in adherent cell cultures.
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Hybridoma Cell Lines
IL-ASl/anti CD-8:

The immortal cell line IL-ASl, a

murine hybridoma cell line producing monoclonal antibody
(IgGl) to the bovine orthologue of human CDS, was obtained
from American Type Culture Collection (ATCC, Rockville, MD).
Cells were cultured at the concentration of 106 cells/ml in
a media comprised of RPMI-1640 supplemented with 10% (v:v)
fetal bovine serum and 20µM 2-Mercaptoethanol.

Cultures

were maintained by adding fresh media every 2-3 days as
needed.
IL-All/anti CD-4:

The immortal cell line IL-All, a

murine hybridoma cell line producing monoclonal antibody
(IgG2a) to the bovine orthologue of human CD4, was obtained
from American Type Culture Collection (ATCC, Rockville, MD).
Cells were cultured at the concentration of 106 cells/ml in
RPMI-1640 supplemented with 10% fetal bovine serum and SOµM
2-Mercaptoethanol.

Cultures were maintained by the addition

of fresh media every 2-3 days as necessary.
T cell/B cell Isolation and Separation Using Monoclonal
Antibodies
Isolation of Antibody from Hybridoma Cultures:

Hybridoma cultures were allowed to grow until culture media
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was turbid.

The hybridoma cell culture flask was then

agitated, lysing cells and maximizing antibody concentration
in the suspension.

Cell suspension was then centrifuged at

2000g at 4°C to sediment large proteins and cell membrane.
The supernatant was poured over a Proteins A/G column,
bacterial products that bind the Fe portion of the antibody,
and purified antibody was eluted from the column using O.lM
glacial acetic acid (pH=2.0).

Absorbance at 206nm of column

effluent was used to indicate antibody elution.
Antibody Biotinylation and Coupling to Magnetic
Microbead: Antibody was conjugated with magnetic microbeads

using the avidin-biotin system.

Briefly, antibody was

dialyzed against O.lM NaHC0 3 (pH=8.4) overnight and
concentration after dialysis determined via spectrophometric
analysis using the Bradford assay.

Antibody was then

concentrated or diluted to obtain a final concentration of 1
mg/ml.

Immediately before use, 1.63 mg of NHS-LC-biotin

(Pierce, Rockford, IL) was dissolved in 1 ml of dimethyl
sulfoxide (DMSO) in a glass tube.

This mixture was

triturated and 50 µl is added to 1 ml antibody solution.
This procedure results in a biotin substitution ratio of
approximately 8:1.

The reaction was allowed to proceed at

105
room temperature for one hour.

The reaction mixture was

then dialyzed against O.lM NaHC0 3 for 48 hours.

Sodium

azide, a cytotoxic substance which protects antibody
integrity, was not used since antibody labeled cells will be
maintained in culture for an extended period (24-48h).
Magnetic-based Cell Separation:

Biotinylated antibody,

anti CD4 or anti CDS, was added to the lymphocyte cell
suspension for 10 min to allow for adequate labeling with
antibody and unbound/excess antibody was removed by three
washes in cold phosphate buffered saline (PBS)

(pH=7.4).

Biotinylated antibody, bound to its respective cell surface
marker, was then coupled to a streptavidin linked magnetic
microbead during a 10 min incubation on ice, a reaction
which occurs due to the high affinity of streptavidin for
biotin (Kd=10- 19 M) .

Cells were washed again in cold PBS and

labeled cells passed over a magnetic column.

In theory, all

cells labeled with magnetically-conjugated antibody should
have been retained on the column while any unlabeled cells
would pass through.

Labeled cells, still bound to magnetic

beads, can then be extruded from the column by removing the
column from the magnetic field and washing several times in
cold PBS.

These cells, still labeled with antibody, may
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then be cultured according to standard conditions.

This

protocol was followed twice for each lymphocyte preparation,
one passage to remove CD4 positive lymphocytes and a second
to remove CDS positive lymphocytes.

B cells were considered

to be those populations which were not labeled by
magnetically linked antibody and thus washed through the
The purity of the cell cultures was ascertained

column.

using FACS analysis and determined to be between 80% and
90%.
G-25 Sephadex Column Gel Filtration

G-25 Sephadex beads (10 g) were combined with deionized
water at a ratio of 1 g per 2-3 ml water yielding a final
volume of approximately 30 ml and equilibrated for 8-10
hours.

This volume was placed in a 2 cm column which was

attached to a continuous perfusion pump with a loop
containing an injection valve and equilibrated with
phosphate buffered saline (PBS, pH 7.2).

Conditioned media

(2 ml) from individual cell cultures was introduced using
the loop.

The molecular weight standard Blue Dextran (MW

2Xl0 6 ) was totally excluded from the beads and provided a
measure of the void volume.

Potassium chromate (MW 194)

totally penetrates the Sephadex beads and was used to

107
reflect the total volume.

Fraction collection (2 ml each)

began when the void volume was eluted and continued until
the total volume was removed from the beads.

Absorbance at

206nm was measured as the fractions were eluted from the
column and was used to indicate the presence of peptide.
Polyacrylamide Gel Electrophoresis (PAGE)

Basic methods were similar to those described by
Schagger and von Jagow (1987) .

In brief, a 20% T separating

gel was prepared containing 3.0 M Tris (pH 8.45) and
glycerol.

This was overlaid with a 10% spacer gel, followed

by a 4% stacking gel (3.0 M Tris, pH 8.45) yielding a gel
with approximate dimensions of 0.75mm X 6.5cm X 9.5cm.

A

discontinuous buff er system was utilized which included a
Tris-base (pH 8.9) anionic buffer and a Tricine/Tris
cationic buffer.

Approximately 20µg of sample was loaded

into each lane and a constant voltage was applied to the gel
(20V for 1 hour followed by lOOV for 1.5 hours).

The gel

was removed from the apparatus once the dye front reached
the anionic buffer-gel interface and stained with silver.
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C. Results

Bioactive peptide is a product of viable mononuclear cells.

Viability of mononuclear cells isolated from bovine
spleen was determined at the time of isolation then at 24
and 48 hours post-isolation using trypan blue.

Figure 10

demonstrates that over this time course viability decreases
significantly at each time point.

Over this same time

course the bioactivity of conditioned media harvested from
these mononuclear cell cultures also diminished (figure 11)
indicating that the bioactive peptide was a viable cell
product.
Nonadherent T and/or B cell populations are the main
mononuclear cell source of bioactive peptide.

Mononuclear cells were separated based on 1 hour
adherence to plastic at 37°C.

Adherent monocyte/macrophage

cell populations and nonadherent T cell and B cell
populations were cultured separately for 24 hours then the
CM was harvested and, using Centricon filters, molecules
>3,000 MW were removed.

Figure 12 shows that only the CM

from the nonadherent cell cultures stimulated significant
epinephrine release from primary chromaffin cell cultures
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TimeO

24h
Spleen #1

48h

TimeO

24h

48h

Spleen #2

Figure 10. Mononuclear cell viability decreases between 24h
and 48h post-isolation. The number of viable cells in
culture were determined based on exclusion of trypan blue.
Results shown are two separate splenocyte preparations.
Similar results were obtained in three other preparations.
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20

15

10

5

O

24h Conditioned 48h Conditioned
Media (CM)
Media (CM)

Spleen #1

RPMI

24h Conditioned 48h Conditioned
Media (CM)
Media (CM)

RPMI

Spleen#2

Figure 11. Conditioned media bioactivity decreases as
mononuclear cell viability decreases. Values given are the
mean ± SEM from the two different splenocyte preparations
utilized in figure 1. Each bar represents 2 triplicates
from one chromaffin cell preparation (n=6).
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Figure 12. Nonadherent T cell and B cell conditioned media
exhibits the majority of bioactivity. Values are the mean ±
SEM from triplicates of two different chromaf fin cell
preparations (n=6).
***=p<0.01 compared to conditioned
media (CM) . Statistics utilized an ANOVA followed by a
Tukey's follow up comparison.
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indicating that these populations are the primary source(s)
of bioactive peptide.
CD4+ cell conditioned media exhibits the majority of
bioactivity.

Nonadherent cell populations were separated into CD4+
or CDS+ T cell populations and B cell populations using
magnetic based cell separation.

A bioassay of CM harvested

from each of these populations revealed that only the CD4+
(T helper) cell CM exhibited any significant bioactivity
(figure 13).

Concurrently, to determine if contact between

different cell populations was necessary to observe maximal
bioactivity, cell populations were recombined and cultured
in various combinations subsequent to separation.

No

significant difference was observed between the bioactivity
of single cell population CM and CM from recombined cell
cultures (data not shown) .
T helper and B cell populations are potential sources of
bioactive peptide.

Conditioned media from CD4+, CDS+, and B cell cultures
was purified using a G-25 Sephadex column.

Based on results

from previous studies, fractions were pooled into groups
which potentially contained bioactive peptide and those
which did not.

Samples from each pooled group (20µg peptide
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which did not.

Samples from each pooled group (20µg peptide

in each) were run on a polyacrylamide gel to determine if
bioactive peptide was present in CM from each population.
Figure 14 shows that both the CD4+ and B cell populations CM
contained bioactive peptide while no peptide was found in
CDS+ cell CM.
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Figure 13. T helper cell conditioned media possesses the
majority of bioactivity. RPMI-1640 represents basal
chromaffin cell secretion. Values are the mean ± SEM from 2
preparations from each of 2 splenocyte preparations (n=4).
This media was then utilized in secretion experiments
performed in triplicate on two chromaff in cell preparations
(n=6).
*=p<0.05 compared to conditioned media (CM) using an
ANOVA and Tukey's follow up comparisons.
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Lane

1 2 3 4 5

Figure 14. Bioactive peptide is produced by T helper (CD4+)
and B cell populations. Samples in each lane are: Lane 1 =
CD4+ cell CM, fractions MW<3,000; Lane 2 = CDS+ cell CM,
fractions MW<3,000; Lane 3 = B cell CM; fractions MW<3,000; .
Lane 4 = Nonadherent Cell CM, Fractions MW <3,000; Lane 5 =
enriched bioactive peptide isolated from total mononuclear
cell cultures. The CD4+, B cell and nonadherent cell
conditioned media all contain peptide of interest while
there is no evidence of the band in CDS+ CM.
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D. Discussion

As research in the area of neural-immune interaction
progresses, it is becoming clear that the immune system and
neuroendocrine system have the capacity to communicate with
each other via common signal molecules and common receptors
(Carr and Blalock, 1991) .

Central to this bidirectional

communication is production of classic neuropeptide hormones
by cells of immune origin.

The first evidence that

leukocytes could synthesize functional neuroendocrine
hormones was obtained from studies which demonstrated that
during the production of interferon alpha (IFNa), virallychallenged human leukocytes coexpressed a peptide which was
antigenically related to the pituitary hormone,
adrenocorticotropin (ACTH)

(Smith and Blalock, 1981)

This

immune-derived ACTH was similar to its pituitary counterpart
with respect to its antigenicity, molecular weight, and
retention time on high pressure liquid chromatography
(HPLC) .

This leukocyte-derived ACTH was shown to have the

same amino acid sequence as pituitary-derived ACTH,
originate from the same precursor, proopiomelanocortin
(POMC), in immune cells as in the pituitary gland (Smith et
al., 1982), and have similar biological activity (Clarke et
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al., 1982), and have similar biological activity (Clarke et
al., 1993) .

Recent investigations have expanded the list of
hormones and neuropeptides produced by immune cells to
include thyrotropin (TSH)
gonadotropin (CG)

(Smith et al., 1983), chorionic

(Harbor-McMennamin et al, 1986), growth

hormone (GH) and prolactin-related peptides (Hiestand et
al., 1986), somatostatin (Lygren et al., 1984; Goetzl et
al., 1985), luteinizing hormone (LH)

(Emanuele et al.,

1990), and vasoactive intestinal peptide (VIP)
al., 1984), among others.

(Lygren et

Although the biological relevance

of immune cell production of such molecules is not yet fully
understood, in vitro experimentation indicates these
hormones and neuropeptides have the capacity to modulate
both neuroendocrine and immune functions

(Koff and Dunegan,

1985; Mercola et al., 1981; Snow, 1985; Payan et al., 1986)
Previously, we have demonstrated that yet another immunederived peptide may be added to this list of potential
immune-neuroendocrine signalling molecules.

This small

peptide (MW<3,000) is released from mononuclear cells (MNC)
and has been shown to stimulate adrenal medullary chromaf fin
cell epinephrine secretion to levels comparable to maximal
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cholinergic stimulation (Jones et al., 1993).
Since all MNC used in these experiments are cultured in
the absence of serum to omit serum-derived growth factors in
the bioassay system, tests were performed to ensure that
serum-free conditions did not alter MNC cell viability.
Potentially, a decrease in viability might imply that the
bioactive component of CM was a MNC death product.
10 and 11 clearly show this is not the case.

Figures

Although MNC

viability does decrease as time in culture increases (figure
10), bioactivity of CM harvested over the given time course
also decreases (figure 11) .

If the bioactive peptide were a

product of MNC death, one would expect bioactivity to
increase as viability decreased.
Further data are presented which demonstrate potential
sources of this mononuclear cell peptide.

Interestingly,

just as cytokine production is unique to specific immune
cell populations, investigations have revealed that not all
immune cells are capable of producing all neuropeptides and
hormones.

For example, in cell cultures stimulated with

endotoxin, B cells, but not T cells synthesize and release
bioactive ACTH and endorphin (Harbour et al., 1991).
Activated CD4+ T lymphocytes, however, appear to be the
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source of opioid peptide in cultures stimulated with the
pineal neurohormone melatonin (Maestroni and Conti, 1991).
The present studies provide evidence that the immune cell
source of the small bioactive peptide is also specific.
Initial results demonstrate that when MNC populations are
separated based on adherence to plastic, the non-adherent T
cell and B cell populations exhibit the majority of
bioactivity (figure 12).

Further separation of these non-

adherent cell populations using specific cell surface
markers revealed that while the CD4+ (T helper) cell CM
possessed the majority of bioactivity (figure 13), both the
CD4+ cell and the B cell are potential sources of the
bioactive peptide (figure 14).

Peptide production by the

CD4+ and B cell populations in the present study, unlike
previously cited works, occurs without mitogenic
stimulation.
al.,

This finding is not surprising in that Kol et

(1983) demonstrated that both mechanical stimulation

and stimulation by density centrifugation media, as would
occur during cell isolation, will activate mononuclear
cells.

This suggests that mononuclear cell isolation in the

present study is a sufficient stimulus for mononuclear cell
bioactive peptide production.
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Identification of specific immune cell source(s) of the
neuropeptides and hormones will provide insight into the
physiologic significance of immune cell production of these
substances.

This information will also aid in understanding

certain aspects of a pathophysiology or disease state based
on an immune cell-specific peptide/hormone.

For example,

lymphocyte-derived CG has been speculated to be an important
suppressive factor necessary for a successful implantation
of the blastocyst and, ultimately, a successful pregnancy
(Blalock, 1994).

In this instance a deficiency of immune

cells that normally produce this CG may be a causative
factor contributing to infertility.

Similarly, deficiency

or dysfunction of CD4+ and/or B cell populations, as in
cases of Acquired Immune Deficiency Syndrome (AIDS) or
Severe Combined Immunodeficiency (SCID) , may lead to
subsequent alterations in bioactive peptide production.

The

lack or dysfunction of cell sources of the bioactive peptide
in these patient populations may have serious ramifications
in communications between the immune and neuroendocrine
systems.

Modifications in peptide release would potentially

impact non-neurogenic catecholamine secretion.

The

implications of this altered neuroendocrine function,
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however, remain to be elucidated.

Further studies

addressing the role of this peptide in homeostatic
mechanisms may help explain specific physiologic
abnormalities when the function of peptide-cell sources
(CD4+, B cell) are impaired.

CHAPTER VI

MONONUCLEAR CELL PEPTIDE MEDIATION OF CHROMAFFIN CELL
EPINEPHRINE SECRETION

A. Introduction

Identification of informational molecules common to the
central nervous system and the immune system such as
cytokines, hormonesi and neuropeptides provides molecular
evidence for bidirectional communication between these
systems (Weigent et al., 1990; Arnason et al., 1991;
Epstein, 1993).

Examples of signalling molecules include

the cytokines tumor necrosis factor-a, interleukin-1, and
interleukin-6 which have been shown to be potent modulators
of the hypothalamic-pituitary-adrenal axis (Imura et al.,
1991).

Additionally, interleukin-1 has been shown to

enhance sympathetic nerve activity (Haefli et al., 1993;
Ichijo et al., 1994), modify the neuronal gene expression of
molecules such as substance P (Jonakait, 1993), and is
122
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synthesized and released by cultured sympathetic neurons
(Frieden et al., 1992).

Current literature indicates that

immune-derived peptides may also play a role in modulating
neural/endocrine function.

In 1981, Blalock and Smith were

the first to report that human peripheral blood lymphocytes
(PBL) infected with Newcastle disease virus (NDV) produced
the proopiomelanocortin (POMC)-derived peptides,
adrenocorticotropin (ACTH) and Beta-endorphin (Smith et al.,
1981; Smith et al., 1982; Clarke et al., 1993)
Interestingly, in studies with mice previously
hypophysectomized to eliminate the pituitary as a source of
ACTH, challenge with NDV significantly elevated plasma
corticosterone levels (Smith et al., 1981; Smith et al.,
1982; Clarke et al., 1993).

Furthermore, glucocorticoids

released in response to immunoreactive-ACTH were shown to
negatively feedback on the immune cells to prevent further
release of ACTH or endorphin.

Thus, products of the immune

system were found to affect output from the adrenal cortex.
Although many details of immune cell-derived ACTH
sequences and processing are recognized (Smith et al.,
1990), such immune cell influences on classic stress
hormones appear to be confined to the adrenal cortex.

As of
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this date there is little evidence that immune cells can
influence the release of the other classic stress hormone
epinephrine, from the adrenal medulla. In contrast, there is
abundant clinical and experimental evidence that infectious
challenge, which activates immune cells, results in profound
epinephrine release which may serve important compensatory
functions to maintain homeostasis (Benedict and GrahameSmith, 1978; Jones et al., 1988).

Although increased

central sympathetic outflow is known to mediate such
epinephrine release (Jones et al., 1988), recent evidence
from this laboratory has shown that non-neural release of
epinephrine during simulated infectious challenge can
contribute approximately 30% of total circulating
epinephrine (Zhou and Jones, 1993).
facts,

In light of these

initial experiments were conducted to test the

possibility that immune cells could mediate epinephrine
release using an in vitro system

(Jones et al., 1993).

These experiments using conditioned media from mononuclear
cells, suggested that a small molecular weight (<3,000)
product(s) of mononuclear cells can cause epinephrine
release from chromaff in cells and that classic nicotinic and
muscarinic neural receptors were not involved.

The goal of
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the present study was to elucidate the physical and
biochemical properties of the immune cell-derived product
and determine if a feedback loop exists.

The present study

provides significant new information about this factor from
mononuclear cells in regard to the specificity of immune
cell-mediated epinephrine secretion.

Most importantly,

electrophoretic experiments suggest that this epinephrine
secretion involves the action of a small molecular weight
peptide.

The present work clearly demonstrates the

potential for circulating immune cells to produce a peptide
which can cause epinephrine release from the adrenal
medulla.

This immune-derived peptide may play a role in the

non-neurogenic epinephrine release in response to infectious
challenge and other stressors.
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B. Materials and Methods
Primary Cultures of Chromaffin Cells
Isolation and Culture: Adult bovine adrenal glands were used

for chromaf fin cell isolation according to the overall
procedure described by Dahmer et al.,

(1990).

In brief,

adrenal glands were perfused with collagenase, incubated at
37°C and medullary tissue removed for further digestion.
Digested cells were washed, counted, and viability
determined with trypan blue staining.

Purity was assessed

using neutral red as described by Role and- Perlman (1980)
Cells were plated on collagen-coated 24-well plates at a
density of 3X10 5 cells per cm 2 and media was changed after
the first day and then as needed to maintain a normal pH.
In vitro Model of Catecholamine Secretion: Basic secretion

experiments are similar to those described by Dahmer et al.,
(1990).

In brief, growth media was removed from each well

and replaced with conditioned media, serum-free RPMI-1640,
Earle's Balanced Salts Solution (EBSS), or secretagogue in
EBSS.

After incubation, media was removed and saved.

Epinephrine content in these samples represent that
stimulated by conditioned media (90 minute incubation),

127

spontaneous/basal secretion (RPMI/EBSS, 90 minute
incubation) , or that stimulated by a known secretagogue
(DMPP/55mM K+, 10 minute incubation) in the presence or
absence of drug/channel blocker.

Cells were then lysed by

adding lM perchloric acid and the acid saved for
determination of the remaining cellular epinephrine content.
Epinephrine secreted into the media as a percent of total
content was calculated by dividing the amount secreted by
the total well content.

Secretion experiments were

routinely done in triplicate using three separate wells on
any one plate all of which were derived from the same
adrenal gland.

Replicates of separate triplicate

determinations were made on cells from different chromaff in
cell preparations.

Analysis of epinephrine was accomplished

with HPLC using electrochemical detection.

Mobile phase

contained O.lM monochloroacetic acid with 0.5mM EDTA and
l.OmM sodium octyl sulfate adjusted to pH 3.0.
was added at 15ml/L.

Acetonitrile

A BAS Liquid Chromatography System

including an LC 4C amperometric detector and glassy carbon
electrode was used in all analyses.
Primary Cultures of Superior Cervical Ganglion (SCG) Cells
Cell Isolation and Culture: Methods are as those
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described previously (Wang et al., 1995).

Briefly, superior

cervical ganglia were dissected from fetal pigs (size: 15-20
cm, gestation age: 6.5-10 weeks) obtained from the local
slaughterhouse.

The surrounding tissue was carefully

removed and the ganglia were transferred to a 0.2%
collagenase-A solution.

After gently stirring for 30 min at

37°C, the ganglia were transferred to a fresh collagenase
solution.
min).

The cell suspension was centrifuged (200Xg; 4

The pellet, containing the dissociated cells was

resuspended in culture medium (Nutrient Mix HAM Fl2)
supplemented with 10% (v/v) horse serum, 1 µg/ml insulin, 1
µg/ml transferrin, 30 ng/ml nerve growth factor, and
antibiotics.

This procedure was repeated several times

until all tissue was digested.

The dissociated cells were

submitted to a differential plating for 2 hours in order to
remove most of the non-neuronal cells.

The cells were

counted in a Coulter counter and plated out at the density
of 2Xl0 4 cells/cm2 in culture flasks or
polyornithine/laminin coated 24 well plates.

Cultures were

maintained at 37°C in a humidified incubator under an
atmosphere of 95%
every 72 hours.

0 2 and 5% C0 2 •

The medium was changed
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In Vitro Model of Catecholamine Secretion:

Superior

cervical ganglia cells were loaded with [ 3 H]norepinephrine
for

2 hours, washed extensively (one 30 min. wash followed

by three 15 min washes), then exposed to conditioned media
or serum-free RPMI-1640 for 90 minutes.

Media was harvested

and supernatant radioactivity and the remaining
radioactivity in each well was determined using the TRI-CARB
460 system (Packard, USA) .

Norepinephrine secreted into the

media as a percent of cell content was calculated as
radioactivity of the supernatant divided by total
radioactivity of the cells in the well.
Digitonin Permeabilization of Chromaffin Cells:

Chromaf fin cells were plated according to described methods
in 24 well plates at 10%, 20%, 40%, 50%, 60%, 80%, 90%, and
100% of the normal/maximal density (6Xl0 5 chromaffin
cells/well) .

All experiments were performed in triplicate

on each chromaffin cell preparation.

Digitonin (20µM)

was

added to each of the wells and allowed to incubate for 20
minutes.

Supernatant from each well was then harvested and

assessed for catecholamine content using HPLC or for lactate
dehydrogenase activity as described below.
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Measurement of Lactate Dehydrogenase Activity in Cell
Supernatant

Lactate dehydrogenase (LDH) activity of chromaffin cell
supernatant was determined using the LDH procedure #500 from
the Sigma Chemical Co.

(St. Louis, MO).

Briefly, 40 µl of

supernatant was added to a cuvette containing 1 ml of the
LDH substrates pyruvate and NADH in phosphate buffered
saline (PBS) .

Absorbance of this solution at 340 nm was

measured each minute for three minutes and the mean change
in absorbance calculated.

LDH activity (U/L) for each

sample was calculated according to the manufacturer's
instructions.
Primary Cultures of Mononuclear Cells from Spleen
Isolation and Culture:

Whole bovine spleen was

obtained from a local slaughter house.

Inner spleen tissue,

which includes both red and white pulp, was dissected out,
cut into small pieces and forced through wire mesh in Hank's
Balanced Salts Solution (HBSS) at room temperature.

Crude

cell suspensions were layered on density gradient media
(Fico/Lite-LymphoH, Atlanta Biologicals) , centrifuged and
then separated.

Isolated cells were washed, viability

assessed using Trypan Blue, and cells were then transferred
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to flasks with RPMI media containing only essential amino
acids and antibiotics.

The growth media was isolated from

the cells after at least 24 hours of culture and either used
promptly or frozen (-20°c).
Characterization of Bioactive Components of Conditioned
Media
Acid Hydrolysis: Conditioned media was harvested from

24-hour mononuclear cell cultures then boiled in acid (3N
HCl)

for 30 minutes.

After boiling, media was brought to

physiologic pH, filtered (Centricon, 3,000 MW cutoff) then
utilized in secretion experiments.
Carboxypeptidase Y and Leucine Aminopeptidase:

Conditioned media was harvested from 24-hour mononuclear
cell cultures then incubated at 37°C either alone or with
enzyme (final concentration of enzyme 25µg/ml) .

After the

specified incubation time, media ± enzyme was centrifuged
through a Centricon filter (3,000 MW cutoff) to remove
peptidase enzyme or other molecules larger than 3,000 MW.
Media was either used promptly in secretion experiments or
frozen (-20°C).
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Peptide Purification and Isolation
G-25 Sephadex Column Gel Filtration:

G-25 Sephadex

beads (10 g) were combined with 30 ml deionized water and
equilibrated for 8-10 hours.

This volume was poured into a

2 cm column which was attached to a continuous perfusion
pump and equilibrated with Phosphate Buffered Saline (PBS,
pH=7.2).

A 2 ml injection loop was used to introduce

conditioned media onto the column with an injection valve.
Blue Dextran (MW 2Xl0 6 ) provided a measure of the void
volume and potassium chromate (MW 194) was used to determine
total volume.

Fraction collection (2 ml each) began when

the void volume was eluted and continued until the total
volume was removed from the beads.

Elution of peptide was

determined by monitoring absorbance at 206nm as the effluent
came off the column.
SDS-PAGE:

Basic methods are similar to those described

by Schagger and von Jagow (1987) .

In brief, a 20% T

separating gel was prepared containing 3.0 M Tris (pH 8.45)
and glycerol.

This was overlaid with a 10% spacer gel,

followed by a 4% stacking gel

(3.0 M Tris, pH=8.45) yielding

a gel with approximate dimensions of 0.75mm X 6.5cm X 9.5cm.
A discontinuous buff er system was utilized which included a
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Tris-base (pH 8.9) anionic buffer and a Tricine/Tris
cationic buffer.

Approximately 20µg of protein was loaded

into each lane and a constant voltage was applied to the gel
(20V for lhour followed by lOOV for 1-1.5 hours).

The gel

was removed from the apparatus once the dye front reached
the anionic buffer-gel interface and silver stained.
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C. Results

Mononuclear Cell Conditioned Media (CM) Stimulates
Chromaf fin Cell Epinephrine Secretion to Levels Comparable
to Maximal Cholinergic Stimulation.

Figure 15 shows that mononuclear cell-derived
conditioned media (CM) stimulates chromaffin cell
epinephrine secretion to levels comparable to maximal
cholinergic stimulation and that induced by depolarizing
concentrations of potassium.

Mononuclear cells used in

these experiments were cultured in the absence of serum to
ensure that the bioactivity of MNC media (CM) was not a
result of serum-derived factors.
CM - Induced Secretion Occurs through Specific, Typical
Exocytotic Processes.

Lactate dehydrogenase (LDH) and modulation of external
calcium were used to determine if CM - induced secretion
occurred through stimulation of specific exocytotic
processes.

In LDH experiments, chromaffin cells were plated

in 24 well plates in concentrations 10, 20, 40, 50, 60, 80,
and 90 percent of the normal conditions (6 X 10 5
cells/well) .

Cells were permeabilized with digitonin (20µM,
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Conditioned
Media(CM)

DMPP

55mMK

+

RPMI-1640
(serum free)

Earle's Balanced
Salts Solution

Figure 15. Conditioned media-induced catecholamine secretion
comparable to maximal cholinergic stimulation. Values given
are mean ±SEM from triplicates of 3 to 6 different
chromaffin cell preparations (n=9 to 18).
***=p<0.001 when
compared to CM, control, or high potassium using an ANOVA
comparison with Tukey's follow-up test.
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Figure 16. Epinephrine content in media of chromaffin cells
permeabilized with digitonin (20µM) for 20 minutes. Maximal
cells (100%) plated per well = 6 X 10 5 in a 24 well plate.
Values given are the mean ± SEM from triplicates of 3
different chromaffin cell preparations (n=9) .
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Figure 17. Lactate dehydrogenase (LDH) activity in media of
chromaffin cells permeabilized with digitonin (20µM) for 20
minutes. Maximal cells plated per well = 6 X 10 5 in a 24
well plate. Values are mean ± SEM. LDH activity (U/L)
defined as the amount of enzyme which catalyzes the
formation of 1 µmol/L of NAD+ per minute under the
conditions of the assay.
***=no detectable LDH activity.
Results obtained from triplicates of 3 different chromaffin
cell preparations (n=9) .
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20 min) then supernatant from each well was assessed for
catecholamine content and LDH activity as previously
described.

With this information, the relationship between

LDH and the catecholamine content was determined.

As

figures 16 and 17 demonstrate, the greater the concentration
of digitonin-permeabilized cells the greater the epinephrine
content and lactate dehydrogenase activity of the
supernatant.

This can be contrasted to the LDH activity and

catecholamine content of cells exposed to CM.

The average

catecholamine released by CM exposure (90 min) was 2.1 µg
per well (figure 16). However, there was no detectable LDH
activity in CM supernatant (figure 17, ***) under the given
experimental conditions indicating that CM stimulated
specific secretory events.

Similar results were obtained

(no detectable LDH activity, significant catecholamine
content) from chromaffin cell media after stimulation with
the nicotinic agonist DMPP (data not shown) .
Classic secretory pathways in chromaf fin cells are
intimately coupled to calcium and bovine chromaf fin cells in
particular are dependent upon the influx of extracellular
calcium to observe secretagogue-induced secretion.
Therefore, the availability of external calcium was
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modulated to determine if CM - induced secretion had a
similar dependence on extracellular calcium.

The influx of

extracellular calcium was inhibited by the non-specific
calcium channel blockers cadmium (O.lmM) and cobalt (2.0mM)
Results presented demonstrate that both cadmium (figure 18)
and cobalt (figures 2 & 18) reduced CM - induced secretion
to levels near or at background indicating CM - induced
secretion is dependent on extracellular calcium influx.
Similar results were obtained using the nicotinic agonist
1,1-Dimethyl-4-Phenylpiperazinium (DMPP, lOµM), a
secretagogue known to be dependent on external calcium to
induce secretion (figure 3).
Evidence that Bioactive Component(s) of CM are Peptide(s)

Evidence that the bioactive component(s) of CM are
peptide in nature is based on acid hydrolysis, enzymatic
treatment, as well as polyacrylamide gel electrophoresis of
purified fractions of CM.

Acid hydrolysis (3N HCl, 100°C)

of CM for 30 minutes significantly reduced the bioactivity
of CM (Figure 19).
µg/ml)

Similarly, carboxypeptidase Y (CY, 25

treatment also significantly decreased CM

bioactivity.

As figure 20 illustrates, increasing

incubation time with CY significantly decreased bioactivity
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3

Figure 23. Silver stain of a modified Schagger gel reveals a
single peptide band in the bioactive fraction from G-25
purified conditioned media.
Lane 1 contains 20µg protein
from total conditioned media (not filtered through Centricon
filter), Lane 2 contains RPMI-1640 cell culture media, and
Lane 3 the bioactive fraction from the G-25 column.

146
of CM when compared to time-matched controls.

CY treatment

did not, however, decrease CM bioactivity to background
levels indicating that the enzymatic digestion was
incomplete (see Discussion, pg 154).

Treatment of CM with

leucine aminopeptidase (LAP, 25µg/ml), unlike CY,
significantly increased the bioactivity of CM when compared
to time matched controls (Figure 21) .
These data suggesting the peptide-nature of bioactive
component(s) of CM are supported by SDS-PAGE electrophoresis
of enriched CM fractions.

Components of CM were separated

on a G-25 column and individual fractions

(2 ml each) were

tested for bioactivity in secretion experiments (figure 22)
Such bioactive fractions were also loaded and
peptide(s)separated on modified Schagger gels via SDS-PAGE.
These gels were subsequently stained with silver.

Figure 23

shows a single peptide band in the lanes taken from
bioactive fractions of CM.

Electroelution of this band from

similar gels also stimulated significant catecholamine
release in secretion experiments when compared to other
electroeluted bands (Figure 24).

Mass spectroscopic

analysis of this peptide determined the putative mass to be
627 Da.
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Conditioned Media Peptide Stimulates Catecholamine Release
from Superior Cervical Ganglia Cell Cultures

To determine if the bioactive peptide could stimulate
catecholamine release from another secretory source, the
sympathetic nerves, CM secretion experiments were performed
on cells from porcine superior cervical ganglia.

Cells

exposed to CM released approximately 2 fold more
[

3

H]norepinephrine as did those exposed to RPMI-1640 alone

(Figure 25).

This effect was concentration-dependent.

Feedback Inhibition by Epinephrine on Mononuclear Cell
Peptide Production

Mononuclear cells were cultured in the presence of
epinephrine to determine if the catecholamine could act in a
classical negative feedback loop to inhibit further immunecell peptide production.

Data presented in figure 26

demonstrates that concentrations of epinephrine as low as
lnM may inhibit release of bioactive peptide and this
inhibition is partially reversed by
with propranolol.

~-adrenergic

blockade
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Figure 24. Electroelution of conditioned media peptides
reveals bioactivity is present only in peptide band of
interest.
Putative bioactive peptide (Band "B") was
electroeluted and bioactivity tested alone; all other
peptides were combined and tested for bioactivity in
secretion experiments. Values are mean ± SEM from two
triplicates on one chromaffin cell preparation (n=6).
**=p<0.01 compared to basal chromaffin cell secretion (RPMI1640) or secretion due to bands > 3,000 MW using an ANOVA
and Tukey's follow up comparisons.
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D. Discussion

Extensive documentation demonstrates that humans
respond to both cognitive and noncognitive stimuli through a
stress response that results in the release of epinephrine
into the circulation (Kjaer and Secher, 1992; Webber and
MacDonald, 1993).

This increased plasma epinephrine has a

wide array of physiologic effects including various
modifications of immune function (Malec et al., 1989;
Mihran-Davis et al., 1991; Rinner et al., 1992; Murray et
al., 1993).

Results of the present study provide evidence

that immune cells are able to synthesize and release a
novel, small molecular weight peptide which modulates
adrenal medullary chromaffin cell epinephrine secretion.
These findings support the concept of bidirectional
communication between the immune system and the adrenal
medulla and suggest a novel mechanism by which circulating
immune cells could mediate epinephrine secretion.
The nervous and immune systems share important
informational molecules such as cytokines, hormones, and
neuropeptides.

These compounds serve as molecular signals

which provide an important link between neural and immune
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systems.

Evidence is accumulating which clearly

demonstrates that not only do the classic immune signalling
molecules, the cytokines (i.e. TNF, IL-6, IL-1)
al.,

(Haefli et

1993; Ichijo et al., 1994; Jonakait et al., 1993;

Frieden et al., 1992; Imura et al., 1991), affect
neuroendocrine function but also that immune cells are
capable of synthesizing and releasing bioactive molecules
which were previously believed to be exclusive to
neuroendocrine systems (i.e. ACTH,

~-endorphin,

CGRP)

(Smith

et al., 1981; Smith et al., 1982; Smith et al., 1983;
Harbor-McMenamin et al., 1986; Hiestand et al.,1986).
Expansion of this list to include a lymphoid-adrenomedullary
interaction through an undescribed lymphocyte product is not
surprising.
The present study provides evidence that a single,
novel small molecular weight peptide is released by MNC and
stimulates adrenal medullary chromaff in cell epinephrine
secretion to levels comparable to maximal cholinergic
stimulation.

Such conclusions are based upon evidence that

isolated preparations of peptide retained bioactivity
(figure 24).

Evidence is also presented that excludes the

potential impact of several extraneous variables in the
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reported immune peptide-chromaffin cell interaction.

For

example, it is possible that the bioactive MNC peptide,
rather than stimulating regulated catecholamine exocytosis,
could have altered chromaffin cell integrity leading to the
leak of catecholamine from cell cultures over the ninety
minute CM incubation.

Lactate dehydrogenase, a cytosolic

enzyme which would leak concurrently with catecholamine if
cell integrity was modified, was not detected in CM after
chromaffin cell incubation (figure 17) while significant
catecholamine was found in this same media (figure 16) .
Furthermore, CM-induced secretion was dependent on the
availability of extracellular calcium (figure 18) indicating
that CM stimulated chromaff in cell epinephrine secretion
through specific, typical exocytotic mechanisms.
Interestingly, the data presented here utilize conditioned
media from MNC which were not stimulated with any mitogenic
factors.

The observed production of bioactive peptide in

the present studies without mitogenic stimulation, however,
is not surprising.

Mechanical stimulation during isolation

of MNC or the documented mitogenic effect of the density
centrifugation media (Kol et al., 1983) may be a sufficient
stimulus of the MNC for bioactive peptide production.
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The peptide nature of the immune cell-derived molecule
in the present study was determined using several different
lines of evidence.

Acid hydrolysis of bioactive CM

significantly decreased the bioactivity (figure 19)
presumably through hydrolysis of the peptide bond(s).

The

peptide nature of the molecule was also demonstrated using
proteolytic digestion.

Incubation of conditioned media with

either carboxypeptidase Y (figure 20) or leucine
aminopeptidase (figure 21) resulted in significant changes
in bioactivity.

However, CY digestion of CM resulted in

incomplete inactivation while LAP treatment of CM
significantly increased bioactivity.

The incomplete

inactivation by CY could be explained by restricted
substrate specificity of the peptidase.

CY activity has

been shown to be limited when the amino acid to the left of
the cleavage is glycine or asparagine or when the residue to
the right of the cleavage site is histidine or lysine.
Potentially, these amino acid residues may be present in the
bioactive peptide and limit CY activity.

The increased

bioactivity of CM after LAP treatment is quite interesting
and may provide a basis for in vivo experimentation.
Conditioned media used in these experiments was not filtered
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(Centricon, 3,000 MW cutoff) until after treatment with LAP
was complete.

The increase in bioactivity is hypothesized

to be a result of LAP cleavage of a larger "parent" molecule
into the small bioactive peptide.

Current investigations

are examining the possibility that endogenous LAP, known to
be released by mononuclear cell populations (Nagaoka and
Yamashita, 1984), could liberate bioactive peptide from a
larger protein.
Additional evidence indicating the peptide nature of
the bioactive factor involved G-25 Sephadex enrichment of CM
and modified SDS-PAGE isolation/purification.

Since

peptides in solution have increased absorbance at 206 nm,
experiments were conducted to determine if there was a
correlation between an increase in absorbance and
bioactivity.

Fractions were obtained from the Sephadex G-25

column which showed increased absorbance at 206 nm as well
as demonstrated high bioactivity (figure 22) .

Peptide-

enriched fractions of CM were then analyzed using gel
electrophoresis.

Separation of peptide(s) using a modified

Schagger gel stained with silver clearly show the presence
of a small peptide (figure 23).

Biological activity of

samples removed from similar gels by electroelution revealed
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that only fractions containing this and no other protein
band(s) stimulated significant catecholamine secretion from
primary chromaffin cell cultures (figure 24) .
Interestingly, CM peptide also stimulates catecholamine
release from in vitro sympathetic ganglion cells.

These

results suggest that the peptide may also enhance
norepinephrine release from peripheral sympathetic nerve
terminals.

These data are consistent with previously

published research demonstrating increased norepinephrine
release at constant nerve activity following a non-cognitive
stimuli (endotoxin)

(Jones et al., 1994).

Additionally,

epinephrine was shown to inhibit mononuclear cell peptide
release and subsequent CM bioactivity (figures 25 &
26),thus, completing a potential physiologic axis.
The putative immune-adrenal medullary axis described in
these studies may have several important clinical
implications. Early in this century, Hans Selye noted that
"diverse noxious agents"

(stressors) produced nonspecific

events that "sick people" share in common.

These "noxious

agents" included both physical agents (non-cognitive
stimuli; i.e. viruses, bacteria, tumors) and emotional
factors (cognitive stimuli) .

The immune-derived peptide
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described in these studies may be one potential mechanism by
which non-cognitive stimuli elicit the release of the stress
hormone epinephrine. An increased systemic epinephrine in
response to peptide would be beneficial during sickness
supporting the hypermetabolism of fever by alterations in
metabolic and cardiovascular function.

Acute elevations in

epinephrine are also associated with enhanced immune
function (Murray et al., 1993; Sanders and Munson, 1985)
which would be equally advantageous in combatting illness.
Prolonged elevation of plasma catecholamine, however, has
been shown to compromise immune function and, thus, would be
detrimental (Malec et al., 1989; Mihran-Davis et al., 1991;
Rinner et al., 1992; Murray et al., 1993).

These studies

suggest that increased epinephrine release as in response to
bioactive peptide may negatively feedback on cells of the
immune system and thus prevent further production of
bioactive peptide.

Removal of the peptide stimulus would

limit further epinephrine secretion and regulate this
immune-neuroendocrine axis.
The results of the present study provide further
evidence for a physical link between the manifestations of
stress and the immune system.

These results also add to the
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growing body of literature describing neuroendocrine-immune
interactions and the potential importance of bidirectional
communication between these systems in maintaining
homeostasis.

Potentially, the disruption of this putative

immune-adrenal medullary axis may be a component of the
pathophysiology of various chronic disease states.
Understanding the capacity of the immune system to respond
to a stressor through a compensatory mechanism and possibly
alter the stress response itself via signalling molecules

(e.g. bioactive peptide) may be useful in predicting disease
onset and outcome.

CHAPTER VII

CHROMAFFIN CELL EPINEPHRINE SECRETION MEDIATED BY A
MACROPHAGE PEPTIDE: THE ROLE OF ENDOTOXIN

A. Introduction

The importance of stress in the etiology and prevention
of disease is becoming increasingly evident as research in
this area progresses (Sheridan et al., 1994).

Traumatic

injury, hemorrhage, as well as infection and its sequelae
are known to create a severe stress on the body.

A tightly

regulated inflammatory/immune response to these types of
stress provides protection from invading pathogens, limits
injury, and promotes healing.

However, in some patients

this response is not regulated and leads to an uncontrolled
systemic response commonly ref erred to as the systemic
inflammatory response syndrome (SIRS) .

SIRS, which may

occur in the presence or absence of infection, is manifest
by changes in white blood cell (WBC) count

159

(>12,000
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cells/mm3 or< 4,000 cells/mm 3 ) and maturity (> 10% immature
bands), changes in body temperature (> 38° C or< 36° C),
tachycardia, and tachypnea (Secor, 1994).

Since the

catecholamines, epinephrine and norepinephrine, have been
shown to have profound effects on the cardiopulmonary system
as well as on immune function, the marked elevations of
plasma catecholamine that occur in response to stress may
play an integral role in the onset and progression of SIRS.
Catecholamines are well recognized to be released by both
the sympathetic nervous system (mainly norepinephrine) and
the adrenal medulla (epinephrine) during a stress response
such as in trauma, hemorrhage or infectious challenge.
While epinephrine secretion from the adrenal medulla is
typically attributed to neural stimulation of medullary
chromaffin cells, recent findings suggest that an immune
cell-derived peptide released from mononuclear cells may
also stimulate the secretion of medullary catecholamines
(Jones et al., 1993).

The present study was undertaken to

test the possibility that endotoxin, a molecule which can
induce SIRS, may stimulate the production/release of
bioactive peptide from immune cells.

Catecholamine

secretion in response to endotoxin-induced release of the
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immune cell-derived peptide may play a role in the altered
cardiopulmonary and immune system function observed during
SIRS and subsequent shock states.
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B. Materials and Methods

Primary Cultures of Chromaffin Cells
Isolation and Culture: Adult bovine adrenal glands were

used for chromaff in cell isolation according to the overall
procedure as described by Dahmer et al.,

(1990).

In brief,

adrenal glands were perfused with collagenase, incubated at
37°C and medullary tissue removed for further digestion.
Digested cells were washed, counted, and viability
determined with trypan blue staining (>98% in all
preparations) .

Purity was assessed using neutral red as

described by Role and Perlman (1980) and was >92% in all
cultures. Cells were plated on collagen-coated 24-well
plates at a density of 3 X 10 5 cells per cm 2 and media
(Dulbecco's Minimum Essential Media, F12, growth inhibitors,
antibiotics, 10% FBS) was changed after the first day and
then as needed to maintain normal pH.
In vitro Model of Catecholamine Secretion: Basic

secretion experimental protocols are those described by
Dahmer et al., (1990).

In brief, growth media was removed

and replaced with either conditioned media (90 min
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incubation), RPMI-1640 (90 min, incubation), modified
balanced salts solution (DMEM, 90 min incubation), or
secretagogue in modified balanced salts solution (DMEM, 10
min incubation) .
saved.

After incubation, media was removed and

Catecholamine content in these samples represents

either that stimulated by conditioned media,
spontaneous/basal secretion (RPMI,salts solution with or
without ETX/PHA), or that stimulated by a known
secretagogue.

Cells are then lysed by lM perchloric acid

and acid was saved to determine the remaining epinephrine
content of the cells.

Total epinephrine secreted into the

media was calculated from the sum of the individual
contents.

Percent chromaffin cell secretion was calculated

by dividing the amount secreted by the total.

Secretion

experiments were routinely done in triplicate using three
separate wells on any one plate which were derived from the
same adrenal gland.

Replicates of separate triplicate

determinations were made on cells from different chromaff in
cell preparations.

Analysis of epinephrine was accomplished

with HPLC using electrochemical detection.

Mobile phase

contained O.lM monochloroacetic acid with O.SmM EDTA and
1.0rnM sodium octyl sulfate adjusted to pH 3.0.

Acetonitrile
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was added at 15ml/L.

A BAS Liquid Chromatography System

including an LC 4C amperometric detector and glassy carbon
electrode was used in all analyses.
Primary Cultures of Mononuclear Cells from Spleen

Whole bovine spleen was obtained from a local slaughter
house.

Inner spleen tissue, which includes both red and

white pulp, was dissected out, cut into small pieces and
forced through wire mesh in salts solution at room
temperature.

Crude cell suspensions were layered on density

gradient media (Lymphoprep) , centrifuged and then separated
cells were removed and washed.

Isolated cells were

transferred to flasks with RPMI-1640 media containing no
serum/growth factors.

Macrophage/monocyte populations were

isolated from other splenocytes based on 1 hour adherence to
plastic in culture flasks at 37° C.

Purity of cultures was

determined by Wright-Giemsa staining and non-specific
esterase activity.

Cultures were either stimulated with LPS

(S. enteritidis,lµg/ml)
SOµg/ml)

or phytohaemagglutinin (PHA,

or left unstimulated.

The growth media was

isolated from the cells and either used promptly or frozen
(-20°c) after at least 24 hours of culture.
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Peptide Purification and Isolation
G-25 Sephadex Column Gel Filtration:

G-25

Sephadex beads (10 g) were combined with 30 ml deionized
water and equilibrated for 8-10 hours.

This volume was

poured into a 2 cm column which was attached to a continuous
perfusion pump and equilibrated with Phosphate Buffered
Saline (PBS, pH 7.2).

A 2 ml by-pass loop connected to the

column was used to introduce conditioned media onto the
column with an injection valve.

Blue Dextran (MW 2Xl0 6 )

provided a measure of the void volume and potassium chromate
(MW 194) was used to determine total volume.

Fraction

collection (2 ml each) began when the void volume was eluted
and continued until the total volume was removed from the
beads.

Elution of peptide was determined by monitoring

absorbance at 206 nm as the effluent came off the column.
SDS-PAGE:

Basic methods are similar to those described

by Schagger and von Jagow (1987).

In brief, a 20% T

separating gel was prepared containing 3.0 M Tris (pH=8.45)
and glycerol.

This was overlaid with a 10% spacer gel,

followed by a 4% stacking gel (3.0 M Tris, pH 8.45) yielding
a gel with approximate dimensions of 0.75mm X 6.5cm X 9.5cm.
A discontinuous buffer system was utilized which included a
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(0.2% w:v, 3 minute incubation) and ammonium sulfate (0.5%
w:v, 3 minute incubation) were added consecutively and the
reaction was allowed to proceed at room temperature.
Finally, samples were incubated with an alcoholic dye base
solution (N-1-Naphthylethylenediamine in ethanol) for 45
minutes at room temperature.

Each sample was transferred to

a cuvette and absorbance (562nm) was read and recorded.
Treatment of CM Fractions with LAP:

The

peptide/protein content of G-25 enriched conditioned media
fractions were characterized using SDS-PAGE .

Fractions

were divided into groups containing the peptide of interest
(group "B") and those containing putative parent molecule(s)
(>

3, 000 MW, group "A") .

Groups "A" and "B" were then each

separated into samples of equal volume.

These samples were

incubated for 5 hours at 37°C either alone or with enzyme
(LAP, 25µg/ml).

After incubation, media ± enzyme was

centrifuged through a Centricon filter (3,000 MW cutoff) to
remove peptidase or other molecules larger than 3,000 MW.
Media was either used promptly in secretion experiments or
frozen ( -2 o0 c) .
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C. Results
ETX enhances bioactivity of conditioned media {CM).

Mononuclear cells isolated from bovine spleen were
cultured 24h in the presence of either ETX (S.
1 µg/ml)

or phytohemagglutinin (50 µg/ml) .

enteritidis,

Media was

harvested, filtered (Centricon) to remove all molecules
greater than 3,000 MW, then used in secretion experiments.
While PHA in culture had no significant influence on CM
bioactivity, the presence of ETX in splenic MNC cultures
significantly enhanced CM bioactivity (Figure 27) .

This

enhanced chromaff in cell epinephrine release in response to
ETX-stimulation, presumably, was due to increased
synthesis/release of bioactive peptide.
Bioactivity in unstimulated cell cultures come from T and/or
B cell populations.

To determine the mononuclear cell population(s) which
significantly contributed to CM bioactivity in nonmitogenically challenged cell cultures, the mononuclear cell
populations were divided based on adherence to plastic and
their CM harvested after 24 hours.

Purity of these cultures

was assessed using Wright-Giemsa and a non-specific esterase
stain and determined to be

>

90%. CM from the nonadherent T
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Figure 27. Endotoxin (ETX) stimulates an increase in
conditioned media (CM) bioactivity. Basal secretion in
serum-free RPMI-1640 ranged from 2-5~ of total cell content
in all experiments. Results are presented as the mean ± SEM
taken from triplicates of one chromaff in cell preparation
(n=3) for each bar.
***=p<0.01 compared to CM using an
ANOVA and Tukey's follow up test. Similar results were
obtained with other chromaffin cell preparations.
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Basal secretion (serum-free RPMI-1640) ranged from 2-5% in
all experiments. Values represent the mean ± SEM from 3
different spleen preparations.
**=p<0.001 compared tu CM
from unseparated MNC cultures using an ANOVA followed by
Tukey's comparisons.
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cell and B cell populations had significantly greater
bioactivity (figure 28) than adherent cell CM from
monocyte/macrophage cell types.
ETX stimulates monocyte/macrophage peptide production.

Mononuclear cell populations were divided based on
adherence to plastic then cultured either in the presence or
absence of ETX (S. enteritidis, lµg/ml)

or PHA (SOµg/ml).

Neither ETX nor PHA significantly altered CM bioactivity
from nonadherent cell populations (figure 29) .

Adherent

monocyte/macrophage CM bioactivity, however, significantly
increased after 24 hour culture with ETX (figure 29).

This

enhanced bioactivity could not be attributed to the action
of ETX on chromaffin cell cultures.
SDS-PAGE analysis of ETX stimulated cultures shows bioactive
band present only in stimulated monocyte/macrophage
cultures.

To determine if bioactive peptide was present in
conditioned media from ETX-treated and non-treated
monocyte/macrophage cell cultures, purified CM peptides from
these cultures were separated using SDS-PAGE.

Each gel also

included lanes containing G-25 enriched bioactive peptide
which had been previously characterized for reference
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in bioactivity of monocyte/macrophage conditioned media
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MNC cultures. Secretion experiments were performed in
triplicate on 2 chromaffin cell preparations (n=6) . Basal
chromaffin cell secretion (serum-free RPMI-1640) ranged from
2-4%" in all experiments.
Basal secretion was unaltered by
the addition of ETX or PHA (see graph). ##=p<0.01 compared
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to unstimulated, unseparated CM. Statistics utilized an
ANOVA followed by Tukey's comparisons.
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Lane

1 2 3 4 5

Figure 30. Endotoxin (ETX) stimulates the release of a
novel, bioactive peptide from monocyte/macrophage
populations.
Samples in each lane are: Lane 1= monocyte () ETX, fractions MW >3,000; Lane 2=monocyte (-) ETX,
fractions MW <3,000; Lane 3=enriched peptide isolated from
total mononuclear cell cultures; Lane 4=monocyte (+) ETX,
fractions MW>3,000; Lane 5=monocyte (+) ETX, fractions MW
<3,000.
The previously characterized bioactive peptide is
only detectable in media from monocytes cultured in the
presence of ETX (Lane 5) .
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-ETX

+ETX

Fold Increase

Conditioned Media

3.45 +/- .2

7.6 +/- .4 (***)

2.2

Macrophage CM

3.24 +/- .6

7.32 +/- 1.3 (**)

2.3

9.36 +/- .3

9.035 +/- .7

1.0

13.8 +/- .2 (##)

1.5

T/B Cell CM
Mouse Serum

9.2 +/- .3

Table 1. Leucit¥: aminopeptidase (LAP) activity is significantly increased in ETXtreated macrophage cultures and endotoxic mouse serum..
Data presented are leudne aminopeptidase activity

exp~

CM= conditioned media
***=p<0.001 compared to CM(-) ETX
**=p<0.01 comapred to Macrophage(-) ETX
##=p<0.01 compared to normal serum (-) ETX

as units per million cells.
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purposes.

While the bioactive peptide band was not present

in non-bioactive CM from unstimulated monocyte/macrophage
cultures, the ETX-challenged monocyte/macrophage CM did
contain the bioactive peptide (figure 30) .
Increased leucine aminopeptidase activity correlates with
increased CM bioactivity.

ETX-challenge of both the total MNC CM and the adherent
cell CM increased the LAP activity of these cultures
approximately 2 fold (table 1) .

Increased LAP activity in

ETX-treated cultures was associated with significantly
increased bioactivity compared to non-treated cultures.
Nonadherent cell CM, which demonstrated significant
bioactivity prior to stimulation, had significant LAP
activity both in the presence or absence of ETX.

The LAP

activity of mouse serum also increased after ETX-challenge
and was approximately 1.5 fold greater than control.
LAP treatment of non-bioactive CM peptides >3,000 MW yields
bioactivity.

G-25 Sephadex enriched fractions of CM peptides were
separated into two groups.

Group "A" contained all CM

peptides greater than 3,000 MW while group "B" contained
only the bioactive peptide.

While the bioactivity of group
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"B"

(bioactive peptide) was unaltered by LAP treatment, LAP

digestion of group "A" yielded significant bioactivity in a
previously non-bioactive media (figure 31) .
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Figure 31. LAP treatment yields bioactivity from nonbioactive CM proteins (>3,000 MW). G-25 purified fractions
of CM were divided based on peptide content.
Fractions
containing bioactive peptide were pooled and labelled "B"
while others with peptides/proteins >3,000 MW were combined
and labelled "A". Values given are the mean± SEM from two
triplicates from one chromaffin cell preparation (n=6) .
**=p<0.01 compared to group "B" ± LAP using an ANOVA with
Tukey's follow-up comparison.
Similar results were obtained
in two other chromaffin cell preparations.
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D. Discussion

The inflammatory/immune response normally protects the
body and limits the extent of injury.

In the setting of

critical illness and/or severe injury, however, regulation
of this response is often lost for reasons that remain to be
elucidated.

An uncontrolled inflammatory/immune response

combined with infection, inflammation, and/or ischemia often
leads to the development of the Systemic Inflammatory
Response Syndrome (SIRS) , which is frequently associated
with the development of septic shock, multiple organ
dysfunction (MODS), and other complications of critical
illness.

Although multiple mediators are involved in the

inflammatory/immune response,

one of the most influential

mediators of SIRS and subsequent septic shock appears to be
endotoxin (Beutler, 1993).

Endotoxin, through activation of

phagocytic cells (e.g. the macrophage), stimulates the
production and release of potent inflammatory/immune
mediators which include tumor necrosis factor (TNF) and
interleukin-1 (IL-1).

Elevation of these factors leads to

complications such as endothelial damage and metabolic
abnormalities which are associated with SIRS.
Interestingly, these same cytokines have been shown to
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modify neuro/endocrine function via the hypothalamicpituitary-adrenal axis (Imura et al., 1991; Haefli et al.,
1993).

Additionally, IL-1 has been shown to enhance

sympathetic nerve activity (Ichijo et al., 1994), modify
neuronal gene expression of substance P (Jonakait, 1993),
and is synthesized and released by cultured sympathetic
neurons (Frieden et al., 1992).

Since the full

manifestation SIRS and the sequelae that follow appears to
be dependent on both inflammatory as well as hormonal
mediators (Secor, 1994), the ability of immune-derived
signalling molecules (TNF, IL-1 or even CM peptide) to
modulate hormone release may have important clinical
implications in SIRS or septic shock .
Among the hormonal mediators which contribute to
SIRS/septic shock are the catecholamines, especially
epinephrine - a hormone released from the adrenal medulla.
The catecholamines have profound effects on cardiovascular
function, cellular metabolic activity as well as immune cell
function (Kjaer and Secher, 1992; Webber and Macdonald,
1993; Plaut, 1987).

Recent evidence suggests that immune

cells, however, may not only respond to changes in plasma
catecholamine but also may modulate the release of
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catecholamine from the adrenal medulla via a small peptide
(Jones et al., 1993).

This peptide-induced medullary

catecholamine release may be an additional pathway by which
plasma catecholamine is elevated during SIRS and subsequent
septic shock.
The current study demonstrates that ETX, an influential
mediator of SIRS/sepsis, enhances production of this peptide
from mononuclear cell populations.

Media (conditioned

media, CM) taken from ETX-challenged MNC stimulated
significantly more chromaff in cell epinephrine secretion
that did CM from unstimulated or PHA-stimulated MNC cultures
(figure 27) .

Although T and/or B cell populations are the

primary source of peptide in cell cultures not stimulated
with ETX (figure 28), ETX appears to stimulate bioactivity
of CM by inducing peptide release from monocyte/macrophage
cell populations (figures 29 & 30).

Previously we have

demonstrated that treatment of CM with the exopeptidase
leucine aminopeptidase (LAP) significantly increased CM
bioactivity (Jones et al, 1995).

Interestingly, ETX has

been shown to increase protease secretion from macrophage
populations (Nathan, 1987) .

Equally noteworthy is the fact

that monocyte/macrophages synthesize and release LAP
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(Nagaoka and Yamashita, 1984; Becher, 1984).

The premise of

these studies was that ETX-challenge stimulated
monocyte/macrophage LAP release and this LAP was cleaving
some larger protein/peptide to liberate bioactive peptide in
these cultures. Data presented in table 1 showing an
increased LAP activity in ETX-treated monocyte/macrophage
and total mononuclear cell cultures support this hypothesis.
Potentially, this LAP may cleave the bioactive peptide from
a larger parent compound released from the mononuclear
cells.

This idea is also supported by the data in figure 31

which demonstrates that previously non-bioactive CM peptides
(>3,000 MW) exhibit significant bioactivity after 5 hour LAP
treatment.
Much like TNF and IL-1, the bioactive peptide may be an
additional signalling molecule released from ETX-stimulated
monocyte/macrophage populations which is able to modulate
hormone release.

Production of this peptide via proteolytic

cleavage of a larger parent compound is not surprising.
Examples of enzymatic conversion of a promolecule to its
bioactive compound include plasminogen activator, a serinetype proteinase, which converts inactive plasminogen to
plasmin by cleaving a single peptide bond (Dano et al.,
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1985; Reich, 1978).

Proteolytic cleavage of several

promolecules are also involved in the activation of the
complement cascade (Medicus et al, 1976; Mueller-Eberhard,
1981), an integral part of host defense against infections.
Endotoxin stimulation of monocyte/macrophage populations may
stimulate the synthesis and release of both peptidases (e.g.
LAP) and the parent molecule.

These peptidases may then

cleave the parent molecule at the amino terminus thereby
liberating bioactive peptide which would stimulate adrenal
medullary catecholamine release.

Since LAP is an

exopeptidase (i.e. LAP hydrolyzes peptide bonds ar or near
the amino-terminus of the peptide), it is highly unlikely
that LAP is liberating the bioactive peptide from the parent
molecule.

However, highly purified preparations of LAP have

been shown to have traces of contaminating endopeptidases
(Royer and Andrews, 1973; DeLange and Smith,

).

Potentially, endopeptidase contaminants of the LAP utilized
in these experiments may be responsible for clevage of the
parent compound and liberation of bioactive peptide.
The implications and potential applications of this
knowledge are many fold.

Since the imposition of a stressor

(e.g. injury/infectious challenge) disrupts homeostasis, it
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is important to understand how the immune system may
compensate and function during such times of stress.

In

addition, the ability of the immune system to directly
modify the stress response through epinephrine secretion may
prove invaluable in understanding homeostatic mechanisms.
As suggested by a growing body of literature, systems
previously believed to be essentially autonomous (i.e.
immune system) are now considered to share informational
molecules such as cytokines, hormones, and neuropeptides
with other (neural/endocrine/neuroendocrine) systems.
Further evidence delineating other structural or functional
connections between these systems, such as the presently
described CM peptide, only strengthens the concept of
systems interdependence and may potentially aid in
understanding systemic dysfunction.

Once the homeostatic

role of signalling molecules are elucidated, recognizing the
functional role of these molecules in a pathophysiology

(e.g. SIRS/sepsis) may provide a basis for therapeutic
intervention.

CHAPTER VIII

SUMMARY AND CONCLUSIONS

The present dissertation study further identified and
characterized a small molecular weight (<3,000) peptide
which stimulates adrenal medullary catecholamine secretion
to levels comparable to maximal cholinergic stimulation.
The first project in this study addressed the role of
calcium in the signal transduction pathway of peptidestimulated chromaffin cell secretion.

Information obtained

in these studies demonstrated that the calcium-dependent
signalling mechanisms of bioactive peptide are similar to
other known peptide secretagogues.

The second project

focused on the mononuclear cell source of this peptide.

The

data provided by these experiments may provide insight to
the function of the peptide in local immunoregulation or in
intersystems communication.

The third project characterized

the peptide-nature and other properties of the molecule as
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well as isolated the bioactive peptide.

This project was

essential in obtaining a putative molecular weight, as well
as potentially sequencing the isolated molecule.

Finally,

the fourth project examined a potential role for bioactive
peptide in endotoxicosis and subsequent shock states.

These

final studies suggested a role for the peptide in vivo.
As can be integrated from the present study as well as
previous works, a schematic representation of the
significance of immunomodulation of adrenal medullary
catecholamine release is presented in Figure 32.

In

response to non-cognitive stimuli, a large precursor
molecule is released from mononuclear cell populations;
specifically CD4+ T cells, B cells, and endotoxin-challenged
monocyte/macrophage populations.

Endogenous proteases (e.g.

leucine aminopeptidase/LAP) cleave the bioactive peptide
from this "parent" compound.

In circulation, this peptide

may reach the adrenal medulla and stimulate medullary
chromaffin cell epinephrine secretion.

The subsequent

increase in plasma catecholamine may then feedback on the
mononuclear cell populations to inhibit further peptide
production. An extension of this working model may be found
in figure 33.

Since many regulatory molecules previously

186
thought to be limited to the the immune system (e.g., IL-1,
IL-6, TNF) are now known to be expressed by both (Krieger,
1983; Plaut, 1987; Carr and Blalock, 1991) it is possible
that the parent molecule of conditioned media peptide may
also be produced and processed in the CNS or in peripheral
neuroendocrine structures.

This provides a second potential

source for conditioned media peptide modulation of
catecholamine release during a typical stress response.

A

second possibility, as demonstrated in figure 33, is that
CM-peptide may serve an autocrine/paracrine function and
modulate cells of the immune system.

As is depicted in the

figure, studies have shown that peptide signalling molecules
(e.g. ACTH, the endorphins, CG) common to both immune and
neuroendocrine structures have immunoregulatory properties
and are speculated to regulate immune function in vivo
(Blalock, 1992, Blalock, 1994, Weigent et al., 1990)

The

immune cell-derived peptide characterized in this
dissertation study may also serve in some immunoregulatory
capacity.
A final schematic representation constructed from
information provided in this dissertation study, in
combination with current information in the literature, is
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presented in Figure 34.

This figure illustrates the

potential calcium-regulated signalling mechanism of peptideinduced secretion.

Bioactive peptide, similar to other

known peptide-secretagogues (i.e. bradykinin and angiotensin
II), binds to its cell surface receptor on the chromaffin
cell.

This receptor is coupled to a second messenger

system, possibly via phophoinositide metabolism, which
stimulates release of calcium from intracellular stores as
well as extracellular calcium influx.

Temporally, this rise

in intracellular calcium in response to peptide would reach
a peak quite quickly due to calcium influx as well as
release from internal stores.

A secondary, long term phase

increase in internal calcium concentrations resulting from
the influx of extracellular calcium would follow.

Evidence provided in this dissertation study in support
of figures 32, 33, and 34 are enumerated as follows.

The

first project evaluated the signal transduction mechanism of
this peptide.

Specifically, the study utilized

pharmacologic agents as well as a fluorescent dye indicator
to address the role of calcium in peptide-induced secretion.
Summary of results from the first project:
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1. Extracellular calcium is essential for peptide-induced
secretion.
2. Release of calcium from intracellular stores are not
required for peptide induced-secretion.
3. Voltage-gated calcium channel blockers do not completely
inhibit secretion in response to peptide stimulation.
4. The rise in intracellular calcium in response to peptide
is biphasic.
5. Peptide-induced increase in intracellular calcium is due
to release from internal stores as well as influx from the
external environment.

Conclusions drawn from the first project:
1. The calcium dependence of peptide-induced secretion is
similar to other known peptide secretagogues.
2. The biphasic, long term elevation in intracellular
calcium may be one of the reasons for the substantial
chromaff in cell epinephrine secretion, comparable to maximal
cholinergic stimulation, in response to peptide.

The second project of this dissertation study
identified potential mononuclear cell source(s) of bioactive
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peptide.

Specifically, mononuclear cell populations were

separated utilizing cell-specific characteristics and
immunologic methods.

The presence of peptide in the

conditioned media from each population was assessed using
bioassay and polyacrylamide gel electrophoresis.
Summary of results from project two:
1. The bioactive peptide is a product of viable mononuclear
cells.
2. T helper (CD4+) cell population conditioned media is
significantly bioactive.
3. B cell populations produce bioactive peptide.

Conclusions from the second project:
1. Since the peptide is a product of viable cells in vitro
it may be an immune cell product in vivo.
2. T helper cells release the majority of peptide, although
B cells are a potential source.

The third project further isolated and characterized a
single mononuclear cell peptide which possessed the majority
of conditioned media bioactivity.

Specifically, conditioned

media was tested using several enzymatic and proteolytic
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tests to determine the nature of the bioactive factor(s).
Bioactive component(s) were further separated and isolated
using SDS-PAGE.
Summary of results from the third project:
1. Lactate dehydrogenase is not present in conditioned media
after exposure to bovine chromaff in cells while significant
amounts of catecholamine are in the media.
2. Calcium is an essential component of peptide-induced
secretion.
3. Acid hydrolysis of conditioned media significantly
decreased bioactivity.
4. Peptidase treatment altered bioactivity of conditioned
media.
5. SDS-PAGE of enriched fractions of conditioned media
revealed the most bioactive fractions contained a single
peptide band.
6. The single peptide band, electroeluted from the gel,
exhibited bioactivity whereas other conditioned media
peptides did not.
7. Conditioned media peptide stimulates norepinephrine
release from cultured sympathetic ganglion cells.
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8. Mononuclear cell co-culture with epinephrine

significantly reduces bioactivity of conditioned media.

Conclusions from project three:
1. Conditioned media-induced secretion is a discrete
exocytotic event.
2. Bioactive factor in conditioned media is a peptide.
3. The majority of conditioned media bioactivity is due to a
single, small molecular weight peptide (627Da) .
4. Conditioned media peptide may stimulate both adrenal
medulllary epinephrine secretion as well as norepinephrine
release from sympathetic nerve terminals.
5. Feedback regulation is suggested by significant decreases
in CM bioactivity subsequent to mononuclear cell challenge
with physiologically relevant concentrations of epinephrine.

The final project of this study addressed the potential
role of this peptide in the long-term elevation of plasma
catecholamine observed in endotoxicosis.

Specifically, in

vitro techniques were utilized to determine conditioned
media bioactivity and identify the presence of peptide in
mononuclear cell cultures before and after challenge with
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endotoxin.

Significant bioactivity and presence of peptide

were then correlated with the activity of a metalloprotease,
leucine aminopeptidase.

Summary of results from the fourth project:
1. Conditioned media from monocyte/macrophage populations
stimulates chromaff in cell epinephrine secretion only after
challenge with endotoxin.
2. SDS-PAGE analysis of monocyte/macrophage conditioned
media revealed that peptide band is present only in
endotoxin-treated cultures.
3. Leucine aminopeptidase activity increased in endotoxin
treated conditioned media from total mononuclear cell
cultures and in monocyte/macrophage cultures.
4. Leucine aminopeptidase treatment of non-bioactive
conditioned media peptides (MW>3,000) led to significant
bioactivity.

Conclusions drawn from project four:
1.

Monocyte/macrophage populations may be an important

source of peptide in infectious/shock states.
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2. Endotoxic stimuli may liberate proteases which cleave

bioactive peptide from a non-bioactive parent molecule.
3. Endotoxin-liberated peptide may comprise part of the nonneurogenic release of catecholamine and may play a role in
the long-term elevations in plasma catecholamines observed
in septic shock.

For centuries a link has been noted between stressful
periods in life, as a result of cognitive and non-cognitive
factors, and illness (Selye, 1936; Selye, 1975; Kort, 1994).
While many mechanisms are possible, a growing body of
literature indicates that stress-induced dyshomeostasis is
largely a result of interactions between the immune and
neuroendocrine systems (Sheridan et al., 1994)

Hormonal

mediators of the stress response (i.e. the catecholamines
and the glucocorticoids) have been shown to have profound
effects on immunologic function.

Both the corticosteroids

and the catecholamines inhibit many functions of leukocytes
and alter their trafficking patterns.

In addition, these

stress hormones modulate production of various cytokines and
inflammatory mediators as well as modulate the effects of
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these substances at various target tissues (Chrousos and
Gold, 1992).
Interestingly, recent evidence suggests that not only
do the stress hormones effect immunologic function, but also
many immune-derived signalling molecules may modulate stress
hormone release.
interleukins-1 and

For instance, cytokines such as
-6 (IL-1,

IL-6) and tumor necrosis

factor (TNF) are all potent modulators of the hypothalamic
pituitary adrenal axis (Imura et al., 1991; Haefli et al.,
1993 ) .

Additionally, IL-1 has been shown to enhance

sympathetic nerve activity (Ichijo et al, 1994).

Finally,

numerous endogenous, potentially immune-derived substances
such as histamine (Bunn and Boyd, 1992), bradykinin (Owen et
al., 1989), and angiotensin II

(Powis and O'Brien, 1991) may

stimulate catecholamine release from the adrenal gland.
The present dissertation study isolated and
characterized a single, novel mononuclear cell-derived
peptide which stimulates adrenal medullary catecholamine
secretion to levels comparable to maximal cholinergic
stimulation.

This peptide, derived from T helper, B cell

and endotoxin activated monocyte/macrophage cell
populations, stimulates chromaffin cell epinephrine
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secretion in a calcium dependent manner similar to other
known peptide secretagogues.

Furthermore, in vitro evidence

suggests a role for this peptide in the elevation of plasma
catecholamines seen in endotoxicosis.

Finally, polyvalent

antisera was obtained in this study which significantly
inhibited conditioned media bioactivity (See Appendix)
indicating the presence of an antibody specific for CMpeptide.

This antisera was also used to develop methods for

an enzyme-linked immunoabsorbent assay (ELISA) which may be
utilized in future experimentation to screen for bioactive
peptide (See Appendix) .
Based on data obtained from the current work, further
studies could be developed to determine the physiologic
significance this peptide.

The most important of these

would be to sequence the isolated peptide as well as its
parent molecule.

Such information would provide a basis for

production of peptide in large quantities to use in
controlled in vitro and in vivo experimentation.

For

example, in vitro experiments could utilize pure peptide to
assess the immunomodulatory properties, if any, of the
molecule.

Pure peptide may also be used to study, in

greater detail, the calcium-dependent signal transduction
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mechanism of the peptide.

This sequence data could also be

utilized to develop a Radioimmunoassay (RIA) .

An RIA is

often utilized to quantitate small molecular weight peptides
(e.g., bioactive peptide) since these small molecules lack
the two non-overlapping epitopes required to perform
commercially utilized sandwich ELISAs.

This RIA, in

conjunction with the already developed compeptitive ELISA,
may be utilized in prospective whole animal studies to
screen for and quantitate peptide in either the sera or
various other compartments of animals during immunologic
challenge.

RIA/ELISA data which indicated that the peptide

concentration increased in an animal population in response
to a specific stimuli (e.g. endotoxin challenge) would then
provide a basis for future in vivo experimentation.

In vivo

experimentation may include the use of anti-peptide
antibody.

Diminished plasma catecholamine in

immunologically-challenged (e.g. endotoxin) animals treated
with anti-peptide antibody versus endotoxic, untreated
animals would indicate a cause-effect relationship between
peptide and catecholamine release. Such specific action
could be confirmed by infusing the peptide into animals and
comparing plasma catecholamine levels to that in control
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animals.

These studies would add important new information

as to how this peptide may play a role in homeostatic
mechanisms.

Knowledge of signalling molecules involved in

intersystems communication and their role in homeostasis
make therapeutic manipulation and improved patient treatment
possible.
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Figure 32. Potential in vivo mechanism of bioactive peptide
production.
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Figure 33. Extension of the current working model.
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Figure 34. Potential calcium-dependent signal transduction
mechanism of the bioactive peptide.
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APPENDIX

EVIDENCE OF A POLYCLONAL ANTIBODY
SPECIFIC FOR BIOACTIVE PEPTIDE

Antibodies (Ab), a family of structurally related
glycoproteins produced/secreted by B cells, mediate the
protective effects of humoral immunity by binding foreign
substances referred to as antigens (Ag) .

Each B lymphocyte

produces antibody of single specificity responsible for
recognition and targeting of a single antigen.

Several

powerful experimental techniques have been developed based
on the specificity of antibody-antigen interaction.

One of

these techniques is the enzyme linked immunoabsorbent assay
(ELISA) .
The ELISA is an immunologic technique (figure 35) by
which one can quantify antigen (e.g. bioactive peptide)
concentrations by using an indicator molecule coupled
covalently to an enzyme.

Antigen is quantified by

determininig the initial rate at which an enzyme converts a
clear substrate in the solution to a colored product.
Experiments in this study utilized anti-peptide antibody
202
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SANDWICH ELISA

COMPETITIVE ELISA

/enzyme Aenzyme

\fty·y/~
*secondary antibody specific
for non-overlapping epitopes
of antigen.
**increasing (antigen]= more
secondary antibody bound=
increased enzymatic color change.

) ' =Primary antibody

'J"

=Secondary antibody

*increasing [free antigen] competes
with fixed amount of immobilized antigen
for antibody: free antigen-antibody
is washed away.
**increasing (free antigen I=
less antibody-immobililz.ed antigen
binding= less color change.

I = Free Antigen
=Immobilized Antigen

**enzyme (eg horseradish peroxidase) converts substrate placed in well (eg DAB)
into colored product. Based on absorbance units. the intensity of the color change
is proportional to [antigen] bound by antibody.

Figure 35. Diagram of Enzyme Linked Immunoabsorbent Assays
(ELISA) .
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obtained from rabbit antisera to develop an ELISA specific
for bioactive peptide.
Detailed methods for antibody production and
development of ELISA may be found in Chapter III.

Briefly,

concentrated peptide, previously characterized using SDSPAGE, was attatched to a 96 well assay plate and incubated
overnight at 4°C.

Although a range of pH conditions were

tested, physiologic pH (7.4) was sufficient to provide
adequate peptide attachment to the plate.

Concurrently, CM

peptides >3,000 MW, Keyhole Limpet Hemocyanin (KLH)
immunogen, KLH-linked peptide, bradykinin, angiotensin II,
and rabbit antisera (primary/1° antibody were attached to
plate wells using similar protocol.

Large molecular weight

CM proteins/peptides were attached to plates to screen for
the presence of parent compound"s" reactive to antibody.
Keyhole Limpet Hemocyanin (KLH) and KLH-linked peptide were
used since this carrier-protein complex was used to
challenge rabbits to produce antisera.

Bradykinin and

angiotensin II, small peptides unrelated to CM-peptide, were
used as controls to determine background and antibody crossreactivity.

Finally, primary antibody (rabbit antisera) was
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attached to plates to ensure that the secondary (2°)
antibody (goat anti-rabbit IgG) bound primary.
After peptide/protein attachment, wells were washed
(PBS/0.05~

Tween-20) and active sites blocked with 0.05%

gelatin (room temperature, 2h).

Wells were washed again

(PBS/Tween solution) then serial dilutions of rabbit
antisera (50, 100, 250, 500, 1000, 5000 fold) were added to
the wells and allowed to incubate (lh, 37°C; overnight,
4°C) .

To measure the amount of specifically bound antisera,

each well was incubated with horseradish peroxicase (HRP)
coupled secondary antibody (goat anti-rabbit antibody,
Accurate Chem. Corp., Westbury, NY)
temperature.

for 2h at room

Wells were washed at least three times with

PBS/Tween then 0.5ml DAB Peroxidase substrate was added.
The reaction between the peroxidase enzyme on the 2°antibody and the substrate are as follows:
Peroxidase (HRP) + H20 2

-------------->

0 2 + 2H20

0 2 + DAB ------------> insoluble, brown-black
precipitate
Absorbance at 492nm was the indicator of the presence of
reactive antibody.
Results obtained from 12 ELISA plates all indicated the
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presence of anti-peptide antibody in the rabbit sera.

An

example of data taken from these studies appears in table 2.
Similar studies were performed using the slot-blot
technique.

This technique involves blotting a membrane

(i.e. nitrocellulose) with peptide/protein which adheres to
the membrane.

The membrane is then incubated with blocking

solution, primary antibody, and secondary antibody in a
protocol similar to that described for the ELISA.

Data from

the slot-blot experiments strongly support results obtained
using the ELISA.
Interestingly, as can be seen in table 2, the antibody
appears to bind a CM peptide/protein of MW>3,000 - a
putative parent molecule.

Limited studies utilizing Western

blot analysis demonstrates that the antisera binds not only
the peptide but also a larger CM peptide/protein.

These

same peptide bands are not detected by preimmune sera,
further supporting antibody specificity.
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Primary Antibody
(dilutions)

"A "
"B "
AII/B:R
Aprotinin

1:100
0.348
0.289
0.218
0.111

1:500
0.233
0.200
0.212
0.105

Preimmune Serum
(dilutions)
1:1000
0.212
0 152
0.200
0.103

1:100
0.231
0 176
0.196
0.102

1:500
0.212
0.146
0.214
0.122

Secondary
Ab Alone
1:1000
0.121
0.146
0.161
0.123

Table 2. Enzyme Linked Immunoabsorbent Assay (ELISA) results
indicate the presence of antibody to a bioactive peptide
epitope.
"A"=potential parent compound(s); "B"=peptide band
of interest; ATII/Br= Angiotensin II/Bradykinin (indication
of background absorbance) . Results presented are absorbance
units (492nm) from wells on a 96 well plate.
Similar
results were obtained in 11 other samples.
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The specificity of this anti-peptide antibody was
further confirmed using a competitive ELISA.
similar to those described previously.

Methods were

In the competitive

ELISA, however, a fixed quantity (O.lOmg peptide) was added
to the diluted antisera prior to its addition to the wells.
This peptide then "competed" against the peptide attached to
the well for anti-peptide antibody.

Table 3 demonstrates

that specific binding diminished more than 80% in the
presence of excess peptide.
Finally, direct proof of a relevant antibody was
obtained via secretion experiments in the presence and
absence of anti-peptide antibody.

Antisera significantly

inhibitted secretion in response to conditioned media
(Figure 36).

This inhibition was not observed with a

similar concentration of preimmune sera.

Secretion in the

presence of sera alone (in RPMI-1640) was not significantly
different than basal secretion.

These results indicate the

presence of a relatively specific polyvalent antibody to CMpeptide in immunized rabbit sera.
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(-)Peptide

(+)Peptide

"A" Fractions

0.231 +/-.006

0.133+/-.006

Bioactive Peptide

0.212+/-.004

0.132+/-.002

KLH-Peptide

0.243+/-.004

0.148+/-.003

Table 3. Bioactive peptide significantly reduces antibody binding to immobilized
peptide/parent protein. Peptide/parent compound attached to 96 well plates was
incubated in with rabbit antisera ( 1: 100 dilution) in the presence (+) or absence (-) of

bioactive peptide (O. lmg). Antisera binding of immobilized peptide/protein was assessed
according to ELISA protocol. Numbers mean absorbance (492nm) +/- SEM from two
triplicate determinations (n=6).
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Figure 36.
Anti-peptide antibody significantly inhibits
conditioned media (CM) bioactivity. Secretion experiments
used filtered (Centricon, 3,000 MW cutoff) conditioned media
in the presence or absence of rabbit antisera (1:100
dilution) or preimmune sera (1:100 dilution) over a 90
minute time course. RPMI-1640 indicative of basal
secretion. Values presented are mean ± SEM from two
triplicates from one chromaffin cell preparation (n=6)
***=p<0.001 compared to CM.
Comparisons were made using an
ANOVA with Tukey's follow-up test.
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